DK2413693T3 - Substituted azoanthracenderivater, pharmaceutical compositions and methods for use thereof - Google Patents
Substituted azoanthracenderivater, pharmaceutical compositions and methods for use thereof Download PDFInfo
- Publication number
- DK2413693T3 DK2413693T3 DK10779665.8T DK10779665T DK2413693T3 DK 2413693 T3 DK2413693 T3 DK 2413693T3 DK 10779665 T DK10779665 T DK 10779665T DK 2413693 T3 DK2413693 T3 DK 2413693T3
- Authority
- DK
- Denmark
- Prior art keywords
- phenyl
- benzyloxy
- amino
- dichloro
- propionic acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 347
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 256
- -1 benzothiopheneyl Chemical group 0.000 claims description 205
- 239000000203 mixture Substances 0.000 claims description 195
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 158
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 69
- 125000000217 alkyl group Chemical group 0.000 claims description 55
- 125000001424 substituent group Chemical group 0.000 claims description 55
- 229910052757 nitrogen Chemical group 0.000 claims description 52
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 38
- 125000003118 aryl group Chemical group 0.000 claims description 36
- 239000001257 hydrogen Substances 0.000 claims description 36
- 229910052739 hydrogen Inorganic materials 0.000 claims description 36
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 36
- 150000003839 salts Chemical class 0.000 claims description 35
- 125000000623 heterocyclic group Chemical group 0.000 claims description 33
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 31
- 125000001072 heteroaryl group Chemical group 0.000 claims description 30
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 30
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 24
- 125000000304 alkynyl group Chemical group 0.000 claims description 22
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 22
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 21
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 20
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 19
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 18
- 229910052736 halogen Inorganic materials 0.000 claims description 18
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 201000010099 disease Diseases 0.000 claims description 17
- 125000003342 alkenyl group Chemical group 0.000 claims description 16
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 15
- 150000002367 halogens Chemical class 0.000 claims description 14
- 125000004429 atom Chemical group 0.000 claims description 13
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 12
- 125000005842 heteroatom Chemical group 0.000 claims description 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 11
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 9
- 125000002947 alkylene group Chemical group 0.000 claims description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 9
- 239000011593 sulfur Chemical group 0.000 claims description 9
- 125000004419 alkynylene group Chemical group 0.000 claims description 8
- 125000001153 fluoro group Chemical group F* 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 7
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 7
- 150000002431 hydrogen Chemical class 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 208000002705 Glucose Intolerance Diseases 0.000 claims description 6
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims description 5
- 239000000556 agonist Substances 0.000 claims description 5
- 125000004350 aryl cycloalkyl group Chemical group 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 206010012601 diabetes mellitus Diseases 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 5
- 125000004076 pyridyl group Chemical group 0.000 claims description 5
- 201000001320 Atherosclerosis Diseases 0.000 claims description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 125000005275 alkylenearyl group Chemical group 0.000 claims description 4
- 239000003472 antidiabetic agent Substances 0.000 claims description 4
- 125000002541 furyl group Chemical group 0.000 claims description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 4
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 4
- 201000000083 maturity-onset diabetes of the young type 1 Diseases 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000002971 oxazolyl group Chemical group 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 201000009104 prediabetes syndrome Diseases 0.000 claims description 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 4
- 125000000335 thiazolyl group Chemical group 0.000 claims description 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 3
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 3
- 208000032928 Dyslipidaemia Diseases 0.000 claims description 3
- 206010022489 Insulin Resistance Diseases 0.000 claims description 3
- 208000017170 Lipid metabolism disease Diseases 0.000 claims description 3
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 201000001421 hyperglycemia Diseases 0.000 claims description 3
- 125000002883 imidazolyl group Chemical group 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 208000011580 syndromic disease Diseases 0.000 claims description 3
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 3
- 206010003210 Arteriosclerosis Diseases 0.000 claims description 2
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims description 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 2
- 206010070901 Diabetic dyslipidaemia Diseases 0.000 claims description 2
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 claims description 2
- 102000004877 Insulin Human genes 0.000 claims description 2
- 108090001061 Insulin Proteins 0.000 claims description 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims description 2
- 208000008589 Obesity Diseases 0.000 claims description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 2
- 125000005218 alkyleneheteroaryl group Chemical group 0.000 claims description 2
- 229940125708 antidiabetic agent Drugs 0.000 claims description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 claims description 2
- 208000006575 hypertriglyceridemia Diseases 0.000 claims description 2
- 230000001771 impaired effect Effects 0.000 claims description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 229940125396 insulin Drugs 0.000 claims description 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 235000020824 obesity Nutrition 0.000 claims description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 2
- 230000029663 wound healing Effects 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims 3
- HPYNZHMRTTWQTB-UHFFFAOYSA-N 2,3-dimethylpyridine Chemical compound CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 claims 2
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 claims 2
- 229940123208 Biguanide Drugs 0.000 claims 2
- 102000023984 PPAR alpha Human genes 0.000 claims 2
- 108010028924 PPAR alpha Proteins 0.000 claims 2
- 230000003178 anti-diabetic effect Effects 0.000 claims 2
- 125000004803 chlorobenzyl group Chemical group 0.000 claims 2
- 125000000068 chlorophenyl group Chemical group 0.000 claims 2
- 125000002946 cyanobenzyl group Chemical group 0.000 claims 2
- 125000004175 fluorobenzyl group Chemical group 0.000 claims 2
- 125000001207 fluorophenyl group Chemical group 0.000 claims 2
- 125000004344 phenylpropyl group Chemical group 0.000 claims 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 1
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 claims 1
- ROJNYKZWTOHRNU-UHFFFAOYSA-N 2-chloro-4,5-difluoro-n-[[2-methoxy-5-(methylcarbamoylamino)phenyl]carbamoyl]benzamide Chemical compound CNC(=O)NC1=CC=C(OC)C(NC(=O)NC(=O)C=2C(=CC(F)=C(F)C=2)Cl)=C1 ROJNYKZWTOHRNU-UHFFFAOYSA-N 0.000 claims 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 1
- SWLAMJPTOQZTAE-UHFFFAOYSA-N 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]benzoic acid Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(C(O)=O)C=C1 SWLAMJPTOQZTAE-UHFFFAOYSA-N 0.000 claims 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 claims 1
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 claims 1
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims 1
- 102000030914 Fatty Acid-Binding Human genes 0.000 claims 1
- 102000004366 Glucosidases Human genes 0.000 claims 1
- 108010056771 Glucosidases Proteins 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 102000000536 PPAR gamma Human genes 0.000 claims 1
- 108010016731 PPAR gamma Proteins 0.000 claims 1
- 206010036049 Polycystic ovaries Diseases 0.000 claims 1
- 229940123518 Sodium/glucose cotransporter 2 inhibitor Drugs 0.000 claims 1
- 229940100389 Sulfonylurea Drugs 0.000 claims 1
- 229940123464 Thiazolidinedione Drugs 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 claims 1
- 230000003262 anti-osteoporosis Effects 0.000 claims 1
- 230000002785 anti-thrombosis Effects 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 239000002220 antihypertensive agent Substances 0.000 claims 1
- 229940030600 antihypertensive agent Drugs 0.000 claims 1
- 239000003524 antilipemic agent Substances 0.000 claims 1
- 239000000164 antipsychotic agent Substances 0.000 claims 1
- 229940005529 antipsychotics Drugs 0.000 claims 1
- 229960004676 antithrombotic agent Drugs 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 125000004802 cyanophenyl group Chemical group 0.000 claims 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 208000033679 diabetic kidney disease Diseases 0.000 claims 1
- 230000009977 dual effect Effects 0.000 claims 1
- 108091022862 fatty acid binding Proteins 0.000 claims 1
- 229960004580 glibenclamide Drugs 0.000 claims 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 claims 1
- 208000037824 growth disorder Diseases 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 208000000509 infertility Diseases 0.000 claims 1
- 230000036512 infertility Effects 0.000 claims 1
- 231100000535 infertility Toxicity 0.000 claims 1
- 229950004994 meglitinide Drugs 0.000 claims 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical group CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 claims 1
- 229960003105 metformin Drugs 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 504
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 287
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 241
- 235000019439 ethyl acetate Nutrition 0.000 description 211
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 203
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 201
- 239000000243 solution Substances 0.000 description 154
- 229940095574 propionic acid Drugs 0.000 description 151
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 127
- 239000000047 product Substances 0.000 description 119
- 239000011541 reaction mixture Substances 0.000 description 114
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 112
- 238000006243 chemical reaction Methods 0.000 description 109
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 96
- 239000012267 brine Substances 0.000 description 93
- 239000012044 organic layer Substances 0.000 description 89
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 84
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 77
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 75
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 70
- 238000003818 flash chromatography Methods 0.000 description 67
- 239000000741 silica gel Substances 0.000 description 60
- 229910002027 silica gel Inorganic materials 0.000 description 60
- 229960001866 silicon dioxide Drugs 0.000 description 60
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 57
- 230000002829 reductive effect Effects 0.000 description 56
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 53
- 239000002904 solvent Substances 0.000 description 53
- 238000005160 1H NMR spectroscopy Methods 0.000 description 49
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 48
- 229910052938 sodium sulfate Inorganic materials 0.000 description 48
- 235000011152 sodium sulphate Nutrition 0.000 description 48
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 46
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 45
- 239000007787 solid Substances 0.000 description 45
- 238000002360 preparation method Methods 0.000 description 42
- 238000003756 stirring Methods 0.000 description 42
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 40
- 239000010410 layer Substances 0.000 description 39
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 32
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 32
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 32
- 150000001412 amines Chemical class 0.000 description 30
- 238000006467 substitution reaction Methods 0.000 description 30
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 29
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 28
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 25
- 125000004432 carbon atom Chemical group C* 0.000 description 23
- 150000002148 esters Chemical class 0.000 description 23
- 229910000027 potassium carbonate Inorganic materials 0.000 description 23
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 22
- 238000001035 drying Methods 0.000 description 22
- 230000007062 hydrolysis Effects 0.000 description 22
- 238000006460 hydrolysis reaction Methods 0.000 description 22
- 239000002253 acid Substances 0.000 description 21
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 20
- 238000004440 column chromatography Methods 0.000 description 20
- 239000000284 extract Substances 0.000 description 20
- GARVSVCVQCGHLY-UHFFFAOYSA-N isoquinoline-7,8-dicarboxylic acid Chemical compound C1=CN=CC2=C(C(O)=O)C(C(=O)O)=CC=C21 GARVSVCVQCGHLY-UHFFFAOYSA-N 0.000 description 19
- 239000003921 oil Substances 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 19
- 238000000746 purification Methods 0.000 description 19
- 229920006395 saturated elastomer Polymers 0.000 description 19
- 239000000377 silicon dioxide Substances 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 18
- 229930040373 Paraformaldehyde Natural products 0.000 description 17
- 229920002866 paraformaldehyde Polymers 0.000 description 17
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 17
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 description 16
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 description 15
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 15
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 15
- 102100040918 Pro-glucagon Human genes 0.000 description 15
- 239000000706 filtrate Substances 0.000 description 15
- 238000010898 silica gel chromatography Methods 0.000 description 15
- 238000003786 synthesis reaction Methods 0.000 description 15
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 14
- NXGKPRKPUCSEIL-UHFFFAOYSA-N 2-acetamido-4-methyl-1,3-thiazole-5-sulfonyl chloride Chemical compound CC(=O)NC1=NC(C)=C(S(Cl)(=O)=O)S1 NXGKPRKPUCSEIL-UHFFFAOYSA-N 0.000 description 14
- CSCPPACGZOOCGX-WFGJKAKNSA-N acetone d6 Chemical compound [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 14
- 208000035475 disorder Diseases 0.000 description 14
- 239000000543 intermediate Substances 0.000 description 14
- TVGLTBPQUIEFBT-SQKCAUCHSA-N methyl (2s)-2-amino-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC(C)=C1C TVGLTBPQUIEFBT-SQKCAUCHSA-N 0.000 description 14
- 229910000029 sodium carbonate Inorganic materials 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 238000005481 NMR spectroscopy Methods 0.000 description 12
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 12
- 150000001408 amides Chemical class 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 235000015320 potassium carbonate Nutrition 0.000 description 12
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 11
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- DNAFOSMJBHMVEX-RPLLCQBOSA-N methyl (2s)-3-[(2s)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound C1=CC([C@@H]2OC3=CC=C(C=C3OC2)C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 DNAFOSMJBHMVEX-RPLLCQBOSA-N 0.000 description 11
- 235000011181 potassium carbonates Nutrition 0.000 description 11
- 238000010992 reflux Methods 0.000 description 11
- XYHIWUWOCXFFNO-WSZLSEGOSA-N (3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C1=CC([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(O)=O)[C@@H](CC)C=2C=CC=CC=2)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 XYHIWUWOCXFFNO-WSZLSEGOSA-N 0.000 description 10
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 10
- SEXYDEKFJLXIME-INIZCTEOSA-N methyl (2s)-2-amino-3-[4-(4-cyanophenyl)phenyl]propanoate Chemical compound C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(C#N)C=C1 SEXYDEKFJLXIME-INIZCTEOSA-N 0.000 description 10
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 10
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 10
- GFUZTXDPFFUWSH-LFHRXCRSSA-N (3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(2-methylpropan-2-yl)oxycarbonyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C1=CC([C@@H]2OC=3C=C4CN(C(CC4=CC=3OC2)C(O)=O)C(=O)OC(C)(C)C)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 GFUZTXDPFFUWSH-LFHRXCRSSA-N 0.000 description 9
- POZQZZZRGZLOGP-UHFFFAOYSA-N 2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2-oxoacetaldehyde Chemical compound C1=C(Cl)C(Cl)=CC=C1COC1=CC=C(C(=O)C=O)C=C1 POZQZZZRGZLOGP-UHFFFAOYSA-N 0.000 description 9
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 9
- 239000012043 crude product Substances 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- BPJQKEYAFMJRCT-PPHPATTJSA-N methyl (3s)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate;hydrochloride Chemical compound Cl.C1=C(O)C=C2CN[C@H](C(=O)OC)CC2=C1 BPJQKEYAFMJRCT-PPHPATTJSA-N 0.000 description 9
- 150000004702 methyl esters Chemical class 0.000 description 9
- ZMCZFLLAEWLKJP-SVNIRARHSA-N 7-o-tert-butyl 8-o-methyl (3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-1,2,3,6,8,9-hexahydropyrido[4,3-g][1,4]benzoxazine-7,8-dicarboxylate Chemical compound C1=CC([C@H]2CNC=3C=C4CC(N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 ZMCZFLLAEWLKJP-SVNIRARHSA-N 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 239000012298 atmosphere Substances 0.000 description 8
- 125000004122 cyclic group Chemical group 0.000 description 8
- COEKCZCWLCNZBB-YLJLHNITSA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 COEKCZCWLCNZBB-YLJLHNITSA-N 0.000 description 8
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical class N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 7
- 229910052731 fluorine Inorganic materials 0.000 description 7
- 238000005984 hydrogenation reaction Methods 0.000 description 7
- QUFUUBBLCOBJPH-UHFFFAOYSA-N isoquinoline-7-carboxylic acid Chemical compound C1=CN=CC2=CC(C(=O)O)=CC=C21 QUFUUBBLCOBJPH-UHFFFAOYSA-N 0.000 description 7
- GTPSYWNNEXIAGW-YLJLHNITSA-N methyl (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=NC(C)=C1C GTPSYWNNEXIAGW-YLJLHNITSA-N 0.000 description 7
- CPHKMDBOUKBUGH-BCLYVYGJSA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate;hydrochloride Chemical compound Cl.C([C@@H](C(=O)OC)NC(=O)C1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 CPHKMDBOUKBUGH-BCLYVYGJSA-N 0.000 description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- LHGRUGVXZLHYKE-UHFFFAOYSA-N 2,5-dimethyl-1,3-oxazole-4-carboxylic acid Chemical compound CC1=NC(C(O)=O)=C(C)O1 LHGRUGVXZLHYKE-UHFFFAOYSA-N 0.000 description 6
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 6
- XPCPSCNPPWMOKH-LBNVMWSVSA-N 7-o-tert-butyl 8-o-methyl (3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C1=CC([C@H]2COC=3C=C4C[C@H](N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 XPCPSCNPPWMOKH-LBNVMWSVSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- 125000004450 alkenylene group Chemical group 0.000 description 6
- 230000029936 alkylation Effects 0.000 description 6
- 238000005804 alkylation reaction Methods 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 125000002993 cycloalkylene group Chemical group 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 6
- IVDOIYGHPJPXFO-NTISSMGPSA-N methyl (2s)-2-amino-3-[4-(4-cyanophenyl)phenyl]propanoate;hydrochloride Chemical compound Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(C#N)C=C1 IVDOIYGHPJPXFO-NTISSMGPSA-N 0.000 description 6
- COEKCZCWLCNZBB-HSIAUZLTSA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)C1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 COEKCZCWLCNZBB-HSIAUZLTSA-N 0.000 description 6
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 6
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 6
- DYUQAZSOFZSPHD-SECBINFHSA-N (1r)-1-phenylpropan-1-ol Chemical compound CC[C@@H](O)C1=CC=CC=C1 DYUQAZSOFZSPHD-SECBINFHSA-N 0.000 description 5
- XRKPZHXBFXMAAN-LBPRGKRZSA-N 2-o-tert-butyl 3-o-methyl (3s)-6-amino-7-hydroxy-3,4-dihydro-1h-isoquinoline-2,3-dicarboxylate Chemical compound NC1=C(O)C=C2CN(C(=O)OC(C)(C)C)[C@H](C(=O)OC)CC2=C1 XRKPZHXBFXMAAN-LBPRGKRZSA-N 0.000 description 5
- JXRGUPLJCCDGKG-UHFFFAOYSA-N 4-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=C(S(Cl)(=O)=O)C=C1 JXRGUPLJCCDGKG-UHFFFAOYSA-N 0.000 description 5
- XPCPSCNPPWMOKH-LSYYVWMOSA-N 7-o-tert-butyl 8-o-methyl (3r,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C1=CC([C@@H]2COC=3C=C4C[C@H](N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 XPCPSCNPPWMOKH-LSYYVWMOSA-N 0.000 description 5
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 description 5
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 5
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 5
- 101001015516 Homo sapiens Glucagon-like peptide 1 receptor Proteins 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 235000013877 carbamide Nutrition 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- GRWIABMEEKERFV-UHFFFAOYSA-N methanol;oxolane Chemical compound OC.C1CCOC1 GRWIABMEEKERFV-UHFFFAOYSA-N 0.000 description 5
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- BNKBYGLZNREPHF-UHFFFAOYSA-N tert-butyl 5-cyano-2-phenylbenzoate Chemical group CC(C)(C)OC(=O)C1=CC(C#N)=CC=C1C1=CC=CC=C1 BNKBYGLZNREPHF-UHFFFAOYSA-N 0.000 description 5
- ZJUUUAXTJOTBPG-HTZKADDXSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1r)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 ZJUUUAXTJOTBPG-HTZKADDXSA-N 0.000 description 4
- MWRGKGDEVBOTCJ-ZCJYOONXSA-N (3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(2-methylpropan-2-yl)oxycarbonyl]-1,2,3,6,8,9-hexahydropyrido[4,3-g][1,4]benzoxazine-8-carboxylic acid Chemical compound C1=CC([C@@H]2OC=3C=C4CN(C(CC4=CC=3NC2)C(O)=O)C(=O)OC(C)(C)C)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 MWRGKGDEVBOTCJ-ZCJYOONXSA-N 0.000 description 4
- GFUZTXDPFFUWSH-RPLLCQBOSA-N (3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(2-methylpropan-2-yl)oxycarbonyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C1=CC([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(O)=O)C(=O)OC(C)(C)C)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 GFUZTXDPFFUWSH-RPLLCQBOSA-N 0.000 description 4
- NWVNEZVJBGTOPC-UHFFFAOYSA-N 2-bromo-1-[4-[(3,4-dichlorophenyl)methoxy]phenyl]ethanone Chemical compound C1=C(Cl)C(Cl)=CC=C1COC1=CC=C(C(=O)CBr)C=C1 NWVNEZVJBGTOPC-UHFFFAOYSA-N 0.000 description 4
- JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-dimethylaminophenol Chemical compound CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 description 4
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- CQXPWEWHJLYDKT-UHFFFAOYSA-N 6-[acetyl(cyclobutylmethyl)amino]-2-methylpyridine-3-sulfonyl chloride Chemical compound C=1C=C(S(Cl)(=O)=O)C(C)=NC=1N(C(=O)C)CC1CCC1 CQXPWEWHJLYDKT-UHFFFAOYSA-N 0.000 description 4
- JHJWDFMAUTZNMI-VWLOTQADSA-N 7-o-tert-butyl 8-o-methyl (8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-8,9-dihydro-6h-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C([C@H](N(CC1=CC=2O3)C(=O)OC(C)(C)C)C(=O)OC)C1=CC=2OC=C3C(C=C1)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 JHJWDFMAUTZNMI-VWLOTQADSA-N 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 229910004373 HOAc Inorganic materials 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 150000001204 N-oxides Chemical class 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 238000006069 Suzuki reaction reaction Methods 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical group 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 4
- WBKFWQBXFREOFH-UHFFFAOYSA-N dichloromethane;ethyl acetate Chemical compound ClCCl.CCOC(C)=O WBKFWQBXFREOFH-UHFFFAOYSA-N 0.000 description 4
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 4
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 description 4
- 239000012458 free base Substances 0.000 description 4
- 125000001188 haloalkyl group Chemical group 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 4
- 239000012948 isocyanate Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- QMEFGOLNZAYOMD-SFHVURJKSA-N methyl (2s)-3-[4-(2,3-dimethylpyridin-4-yl)oxyphenyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound C1=CC(C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1OC1=CC=NC(C)=C1C QMEFGOLNZAYOMD-SFHVURJKSA-N 0.000 description 4
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 229910052703 rhodium Inorganic materials 0.000 description 4
- 239000010948 rhodium Substances 0.000 description 4
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 4
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- FVVBJJMPVXUBQZ-VLSLJKOQSA-N tert-butyl (3s,8s)-8-[[(2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3-(4-hydroxyphenyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(O)=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1C1=CC=NC(C)=C1C FVVBJJMPVXUBQZ-VLSLJKOQSA-N 0.000 description 4
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- 150000003672 ureas Chemical class 0.000 description 4
- 239000003039 volatile agent Substances 0.000 description 4
- HWCDMDXESHLLKF-UHFFFAOYSA-N (2,3-dimethylpyridin-4-yl)boronic acid Chemical compound CC1=NC=CC(B(O)O)=C1C HWCDMDXESHLLKF-UHFFFAOYSA-N 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 3
- SZGNVQBQNCCWEF-JOCHJYFZSA-N (2s)-2-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxine-6-carbonitrile Chemical compound C1=C(Cl)C(Cl)=CC=C1COC1=CC=CC([C@@H]2OC3=CC=C(C=C3OC2)C#N)=C1 SZGNVQBQNCCWEF-JOCHJYFZSA-N 0.000 description 3
- SMCXOOICFFLLPU-NNXAUVBWSA-N (2s)-2-[[(3s,8s)-7-(2,5-dimethyl-1,3-oxazole-4-carbonyl)-3-[4-[[4-(trifluoromethyl)cyclohexyl]methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound O1C(C)=NC(C(=O)N2[C@@H](CC3=CC=4OC[C@@H](OC=4C=C3C2)C=2C=CC(OCC3CCC(CC3)C(F)(F)F)=CC=2)C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C(=C(C)N=CC=2)C)C(O)=O)=C1C SMCXOOICFFLLPU-NNXAUVBWSA-N 0.000 description 3
- ZJUUUAXTJOTBPG-XEYCMZRFSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3r,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(1-phenylpropyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@H](OC=3C=C2CN1C(CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 ZJUUUAXTJOTBPG-XEYCMZRFSA-N 0.000 description 3
- AFDXRJWVBRXFCV-JFNWFBRVSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(2-methoxyphenyl)sulfonyl-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound COC1=CC=CC=C1S(=O)(=O)N1C(C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C=CC(=CC=2)C#N)C(O)=O)CC2=CC(OC[C@@H](O3)C=4C=CC(OCC=5C=C(Cl)C(Cl)=CC=5)=CC=4)=C3C=C2C1 AFDXRJWVBRXFCV-JFNWFBRVSA-N 0.000 description 3
- ZJUUUAXTJOTBPG-URYQKDSJSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(1-phenylpropyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1C(CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 ZJUUUAXTJOTBPG-URYQKDSJSA-N 0.000 description 3
- YTOMHYXKHDUKAG-HRDMKUQISA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(2-nitrophenyl)sulfonyl-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)S(=O)(=O)C=1C(=CC=CC=1)[N+]([O-])=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 YTOMHYXKHDUKAG-HRDMKUQISA-N 0.000 description 3
- GVVCHDNSTMEUCS-MUGJNUQGSA-N (2s,5s)-1-[2-[(2s,5s)-2,5-diethylphospholan-1-yl]phenyl]-2,5-diethylphospholane Chemical compound CC[C@H]1CC[C@H](CC)P1C1=CC=CC=C1P1[C@@H](CC)CC[C@@H]1CC GVVCHDNSTMEUCS-MUGJNUQGSA-N 0.000 description 3
- GFUZTXDPFFUWSH-IGKIAQTJSA-N (3r,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(2-methylpropan-2-yl)oxycarbonyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C1=CC([C@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(O)=O)C(=O)OC(C)(C)C)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 GFUZTXDPFFUWSH-IGKIAQTJSA-N 0.000 description 3
- MBMJQYUNAQBQAB-MQNHUJCZSA-N (3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylic acid Chemical compound C1=CC([C@H]2COC=3C=C4CC(N(CC4=CC=3O2)C(O)=O)C(=O)O)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 MBMJQYUNAQBQAB-MQNHUJCZSA-N 0.000 description 3
- UTFBGCLEKBUODW-QMMMGPOBSA-N (3s)-6-amino-7-hydroxy-3,4-dihydro-1h-isoquinoline-2,3-dicarboxylic acid Chemical compound C1[C@@H](C(O)=O)N(C(O)=O)CC2=C1C=C(N)C(O)=C2 UTFBGCLEKBUODW-QMMMGPOBSA-N 0.000 description 3
- HIKCRLDSCSWXML-VIFPVBQESA-N (3s)-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid Chemical compound C1=C(O)C=C2CN[C@H](C(=O)O)CC2=C1 HIKCRLDSCSWXML-VIFPVBQESA-N 0.000 description 3
- DIDZCKKBVLUIRL-RPLLCQBOSA-N (3s,8s)-3-[4-(cyclohexylmethoxy)phenyl]-7-[(2-methylpropan-2-yl)oxycarbonyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C1=CC([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(O)=O)C(=O)OC(C)(C)C)=CC=C1OCC1CCCCC1 DIDZCKKBVLUIRL-RPLLCQBOSA-N 0.000 description 3
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical class NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 3
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 3
- ICFJDFIWRVTOFU-NSHDSACASA-N 2-o-tert-butyl 3-o-methyl (3s)-6,7-dihydroxy-3,4-dihydro-1h-isoquinoline-2,3-dicarboxylate Chemical compound OC1=C(O)C=C2CN(C(=O)OC(C)(C)C)[C@H](C(=O)OC)CC2=C1 ICFJDFIWRVTOFU-NSHDSACASA-N 0.000 description 3
- PUDPGVZTTKAMBN-LBPRGKRZSA-N 2-o-tert-butyl 3-o-methyl (3s)-7-hydroxy-6-nitro-3,4-dihydro-1h-isoquinoline-2,3-dicarboxylate Chemical compound [O-][N+](=O)C1=C(O)C=C2CN(C(=O)OC(C)(C)C)[C@H](C(=O)OC)CC2=C1 PUDPGVZTTKAMBN-LBPRGKRZSA-N 0.000 description 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 3
- RLJRYMHETNBKOK-UHFFFAOYSA-N 4-(2-acetamido-1,3-thiazol-4-yl)benzenesulfonyl chloride Chemical compound S1C(NC(=O)C)=NC(C=2C=CC(=CC=2)S(Cl)(=O)=O)=C1 RLJRYMHETNBKOK-UHFFFAOYSA-N 0.000 description 3
- XLWSBDFQAJXCQX-UHFFFAOYSA-N 4-(bromomethyl)-1,2-dichlorobenzene Chemical compound ClC1=CC=C(CBr)C=C1Cl XLWSBDFQAJXCQX-UHFFFAOYSA-N 0.000 description 3
- PHCLIPMSNVUELH-UHFFFAOYSA-N 4-bromo-2,3-dimethylpyridine Chemical compound CC1=NC=CC(Br)=C1C PHCLIPMSNVUELH-UHFFFAOYSA-N 0.000 description 3
- GHSRMSJVYMITDX-UHFFFAOYSA-N 6-chloro-2-methyl-3-nitropyridine Chemical compound CC1=NC(Cl)=CC=C1[N+]([O-])=O GHSRMSJVYMITDX-UHFFFAOYSA-N 0.000 description 3
- XPCPSCNPPWMOKH-MPSNESSQSA-N 7-o-tert-butyl 8-o-methyl (3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C1=CC([C@H]2COC=3C=C4CC(N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 XPCPSCNPPWMOKH-MPSNESSQSA-N 0.000 description 3
- COXDNTRTGQEGMA-SFHVURJKSA-N 7-o-tert-butyl 8-o-methyl (8s)-3-(4-nitrophenyl)-8,9-dihydro-6h-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C([C@H](N(CC1=CC=2O3)C(=O)OC(C)(C)C)C(=O)OC)C1=CC=2OC=C3C1=CC=C([N+]([O-])=O)C=C1 COXDNTRTGQEGMA-SFHVURJKSA-N 0.000 description 3
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- 206010061818 Disease progression Diseases 0.000 description 3
- 108010011459 Exenatide Proteins 0.000 description 3
- 108010086246 Glucagon-Like Peptide-1 Receptor Proteins 0.000 description 3
- 102000007446 Glucagon-Like Peptide-1 Receptor Human genes 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 3
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 3
- KHYAFFAGZNCWPT-UHFFFAOYSA-N boron;n,n-diethylaniline Chemical compound [B].CCN(CC)C1=CC=CC=C1 KHYAFFAGZNCWPT-UHFFFAOYSA-N 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 125000004367 cycloalkylaryl group Chemical group 0.000 description 3
- 125000005215 cycloalkylheteroaryl group Chemical group 0.000 description 3
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 3
- 230000005750 disease progression Effects 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000003877 glucagon like peptide 1 receptor agonist Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000005349 heteroarylcycloalkyl group Chemical group 0.000 description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 150000002513 isocyanates Chemical class 0.000 description 3
- OGZJASWLLYAZIA-INIZCTEOSA-N methyl (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate Chemical compound C1=CC(C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1B1OC(C)(C)C(C)(C)O1 OGZJASWLLYAZIA-INIZCTEOSA-N 0.000 description 3
- AEYXEFACMZSBHG-TUYUPMGOSA-N methyl (2s)-2-amino-3-[(2r)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]propanoate;hydrochloride Chemical compound Cl.C1=CC([C@H]2OC3=CC=C(C=C3OC2)C[C@H](N)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 AEYXEFACMZSBHG-TUYUPMGOSA-N 0.000 description 3
- CBZDDKMGJLYWRG-HNNXBMFYSA-N methyl (2s)-2-amino-3-[4-(2,3-dimethylpyridin-4-yl)oxyphenyl]propanoate Chemical compound C1=CC(C[C@H](N)C(=O)OC)=CC=C1OC1=CC=NC(C)=C1C CBZDDKMGJLYWRG-HNNXBMFYSA-N 0.000 description 3
- JJJKCAAPLWARHE-CKUXDGONSA-N methyl (2s)-2-amino-3-[4-(2,3-dimethylpyridin-4-yl)oxyphenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1OC1=CC=NC(C)=C1C JJJKCAAPLWARHE-CKUXDGONSA-N 0.000 description 3
- FDFQRJWLHKSHPZ-LBPRGKRZSA-N methyl (2s)-3-(4-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound CC(C)(C)OC(=O)N[C@H](C(=O)OC)CC1=CC=C(Br)C=C1 FDFQRJWLHKSHPZ-LBPRGKRZSA-N 0.000 description 3
- LXOYICPHPKAIRO-SIKLNZKXSA-N methyl (2s)-3-[(2s)-2-(4-acetyloxyphenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound C1([C@@H]2OC3=CC=C(C=C3OC2)C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C(OC(C)=O)C=C1 LXOYICPHPKAIRO-SIKLNZKXSA-N 0.000 description 3
- UBXVBIYYOUTSRO-WIOPSUGQSA-N methyl (2s)-3-[(2s)-2-(4-acetyloxyphenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(4-nitrophenyl)sulfonylamino]propanoate Chemical compound C1([C@@H]2OC3=CC=C(C=C3OC2)C[C@@H](C(=O)OC)NS(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C(OC(C)=O)C=C1 UBXVBIYYOUTSRO-WIOPSUGQSA-N 0.000 description 3
- UWOYWBGELCFGKB-FXAWDEMLSA-N methyl (2s)-3-[(2s)-2-(4-hydroxyphenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound C1([C@@H]2OC3=CC=C(C=C3OC2)C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C(O)C=C1 UWOYWBGELCFGKB-FXAWDEMLSA-N 0.000 description 3
- ITULJIQPZPCOBS-BHBYDHKZSA-N methyl (2s)-3-[(2s)-2-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(4-nitrophenyl)sulfonylamino]propanoate Chemical compound C=1C([C@@H]2OC3=CC=C(C=C3OC2)C[C@@H](C(=O)OC)NS(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=CC=1OCC1=CC=C(Cl)C(Cl)=C1 ITULJIQPZPCOBS-BHBYDHKZSA-N 0.000 description 3
- RJJDDNNLUJAHLC-WSZLSEGOSA-N methyl (2s)-3-[(2s)-2-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[[(1s)-1-phenylpropyl]amino]propanoate Chemical compound C=1C([C@@H]2OC3=CC=C(C=C3OC2)C[C@H](N[C@@H](CC)C=2C=CC=CC=2)C(=O)OC)=CC=CC=1OCC1=CC=C(Cl)C(Cl)=C1 RJJDDNNLUJAHLC-WSZLSEGOSA-N 0.000 description 3
- CPHKMDBOUKBUGH-NDOUHODOSA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3r,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate;hydrochloride Chemical compound Cl.C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 CPHKMDBOUKBUGH-NDOUHODOSA-N 0.000 description 3
- JVKJKADJNQEXEA-QMMMGPOBSA-N methyl (3s)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate Chemical compound OC1=C(O)C=C2CN[C@H](C(=O)OC)CC2=C1 JVKJKADJNQEXEA-QMMMGPOBSA-N 0.000 description 3
- DYKLPYKFQICXER-ODTVBPJYSA-N methyl (3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylate Chemical compound C1=CC([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(=O)OC)[C@@H](CC)C=2C=CC=CC=2)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 DYKLPYKFQICXER-ODTVBPJYSA-N 0.000 description 3
- LJHAPRKTPAREGO-UHFFFAOYSA-N methyl 2-dimethoxyphosphoryl-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetate Chemical compound COC(=O)C(P(=O)(OC)OC)NC(=O)OC(C)(C)C LJHAPRKTPAREGO-UHFFFAOYSA-N 0.000 description 3
- KSKRPHSHPQTWJK-MHZLTWQESA-N methyl 3-[(2r)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]prop-2-enoate Chemical compound C1=CC([C@H]2OC3=CC=C(C=C3OC2)C=C(NC(=O)OC(C)(C)C)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 KSKRPHSHPQTWJK-MHZLTWQESA-N 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 150000002828 nitro derivatives Chemical class 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 238000006268 reductive amination reaction Methods 0.000 description 3
- 150000003335 secondary amines Chemical class 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 235000010288 sodium nitrite Nutrition 0.000 description 3
- 239000012265 solid product Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 150000003456 sulfonamides Chemical class 0.000 description 3
- QHUVTWQYVYYCIH-UITVWODBSA-N tert-butyl (3s)-8-[[(2s)-3-[4-(4-cyanophenyl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-1,2,3,6,8,9-hexahydropyrido[4,3-g][1,4]benzoxazine-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)C1N(CC2=CC=3O[C@H](CNC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 QHUVTWQYVYYCIH-UITVWODBSA-N 0.000 description 3
- WBMGIEPKPCDHAD-IWJNXRQDSA-N tert-butyl (3s,8s)-3-[4-(cyclohexylmethoxy)phenyl]-8-[[(2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC2CCCCC2)=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1C1=CC=NC(C)=C1C WBMGIEPKPCDHAD-IWJNXRQDSA-N 0.000 description 3
- YZPVIRDQSFKCJS-IWJNXRQDSA-N tert-butyl (3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-8-[[(2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1C1=CC=NC(C)=C1C YZPVIRDQSFKCJS-IWJNXRQDSA-N 0.000 description 3
- RRKODOZNUZCUBN-CCAGOZQPSA-N (1z,3z)-cycloocta-1,3-diene Chemical compound C1CC\C=C/C=C\C1 RRKODOZNUZCUBN-CCAGOZQPSA-N 0.000 description 2
- CMUGKDLRHYPCSS-QFIPXVFZSA-N (2r)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxine-6-carbonitrile Chemical compound C1=C(Cl)C(Cl)=CC=C1COC1=CC=C([C@H]2OC3=CC=C(C=C3OC2)C#N)C=C1 CMUGKDLRHYPCSS-QFIPXVFZSA-N 0.000 description 2
- YDECNSWOIFUDLC-JOCHJYFZSA-N (2s)-2-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxine-6-carbaldehyde Chemical compound C1=C(Cl)C(Cl)=CC=C1COC1=CC=CC([C@@H]2OC3=CC=C(C=O)C=C3OC2)=C1 YDECNSWOIFUDLC-JOCHJYFZSA-N 0.000 description 2
- BUDRXDXIUACVTR-JOCHJYFZSA-N (2s)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxine-6-carbaldehyde Chemical compound C1=C(Cl)C(Cl)=CC=C1COC1=CC=C([C@@H]2OC3=CC=C(C=O)C=C3OC2)C=C1 BUDRXDXIUACVTR-JOCHJYFZSA-N 0.000 description 2
- CMUGKDLRHYPCSS-JOCHJYFZSA-N (2s)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxine-6-carbonitrile Chemical compound C1=C(Cl)C(Cl)=CC=C1COC1=CC=C([C@@H]2OC3=CC=C(C=C3OC2)C#N)C=C1 CMUGKDLRHYPCSS-JOCHJYFZSA-N 0.000 description 2
- UUZSXAUGISGKMS-SIORXBAWSA-N (2s)-2-[[(3s)-7-(benzenesulfonyl)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)S(=O)(=O)C=1C=CC=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 UUZSXAUGISGKMS-SIORXBAWSA-N 0.000 description 2
- DTGFQIGGGWYXHC-DHUDCZEASA-N (2s)-2-[[(3s)-7-(tert-butylcarbamoyl)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)C1CC2=CC=3OC[C@@H](OC=3C=C2CN1C(=O)NC(C)(C)C)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 DTGFQIGGGWYXHC-DHUDCZEASA-N 0.000 description 2
- OXEHLWBZPWIUMM-MHWJKXMPSA-N (2s)-2-[[(3s)-7-[(2-amino-4-methyl-1,3-thiazol-5-yl)sulfonyl]-3-(4-ethoxyphenyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C1=CC(OCC)=CC=C1[C@@H]1OC2=CC(CN(C(C3)C(=O)N[C@@H](CC=4C=CC(=CC=4)C=4C=CC(=CC=4)C#N)C(O)=O)S(=O)(=O)C4=C(N=C(N)S4)C)=C3C=C2OC1 OXEHLWBZPWIUMM-MHWJKXMPSA-N 0.000 description 2
- JHVBEGBKQNSPAI-KNGBNFTKSA-N (2s)-2-[[(3s)-7-[(2-amino-4-methyl-1,3-thiazol-5-yl)sulfonyl]-3-(4-phenylmethoxyphenyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound N1=C(N)SC(S(=O)(=O)N2C(CC3=CC=4OC[C@@H](OC=4C=C3C2)C=2C=CC(OCC=3C=CC=CC=3)=CC=2)C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C=CC(=CC=2)C#N)C(O)=O)=C1C JHVBEGBKQNSPAI-KNGBNFTKSA-N 0.000 description 2
- UJFMGHIFBOGDJZ-YUTPAWSZSA-N (2s)-2-[[(3s)-7-[(2-amino-4-methyl-1,3-thiazol-5-yl)sulfonyl]-3-[4-(cyclopentylmethoxy)phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound N1=C(N)SC(S(=O)(=O)N2C(CC3=CC=4OC[C@@H](OC=4C=C3C2)C=2C=CC(OCC3CCCC3)=CC=2)C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C=CC(=CC=2)C#N)C(O)=O)=C1C UJFMGHIFBOGDJZ-YUTPAWSZSA-N 0.000 description 2
- NMJVMRQXELZJEU-SIORXBAWSA-N (2s)-2-[[(3s)-7-benzoyl-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C=1C=CC=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 NMJVMRQXELZJEU-SIORXBAWSA-N 0.000 description 2
- PYIGYZMESCXTLC-DSMKTCEVSA-N (2s)-2-[[(3s,8s)-3-[4-(cyclopentylmethoxy)phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC2CCCC2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C PYIGYZMESCXTLC-DSMKTCEVSA-N 0.000 description 2
- DQDQVAWHSSGEPH-AMNOJZCUSA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(2-methylpentan-3-yl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1C(C(C)C)CC)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C DQDQVAWHSSGEPH-AMNOJZCUSA-N 0.000 description 2
- UOZPOZDOXYJXIJ-TVAVRQBESA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(pyridin-2-ylmethyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound CC1=NC=CC(C=2C=CC(C[C@H](NC(=O)[C@H]3N(CC4=CC=5O[C@H](COC=5C=C4C3)C=3C=CC(OCC=4C=C(Cl)C(Cl)=CC=4)=CC=3)CC=3N=CC=CC=3)C(O)=O)=CC=2)=C1C UOZPOZDOXYJXIJ-TVAVRQBESA-N 0.000 description 2
- YIKYLHBXYYFCEZ-WWKIHPBISA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-(4-pyridin-4-ylphenyl)propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC=C1 YIKYLHBXYYFCEZ-WWKIHPBISA-N 0.000 description 2
- DEDPYBWOUXWMOX-ZTAAISNPSA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C DEDPYBWOUXWMOX-ZTAAISNPSA-N 0.000 description 2
- GLSFNHSIUULLSS-ZTAAISNPSA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-methylphenyl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C)C=C1 GLSFNHSIUULLSS-ZTAAISNPSA-N 0.000 description 2
- YDEJWKQAAPBIMZ-DSMKTCEVSA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-[2-(fluoromethyl)pyridin-4-yl]phenyl]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(CF)=C1 YDEJWKQAAPBIMZ-DSMKTCEVSA-N 0.000 description 2
- GFHHVMCDGJQWKC-ZTAAISNPSA-N (2s)-2-[[(3s,8s)-3-[4-[(3-chlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C GFHHVMCDGJQWKC-ZTAAISNPSA-N 0.000 description 2
- VDVOMHPLPSQTPY-IFMZLZCVSA-N (2s)-2-[[(3s,8s)-7-acetyl-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1C(=O)C)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C VDVOMHPLPSQTPY-IFMZLZCVSA-N 0.000 description 2
- JUPRHEXJQLPHQL-WRUZSIFFSA-N (2s)-2-[[(3s,8s)-7-benzoyl-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2-methylpyridin-4-yl)oxyphenyl]propanoic acid Chemical compound C1=NC(C)=CC(OC=2C=CC(C[C@H](NC(=O)[C@H]3N(CC4=CC=5O[C@H](COC=5C=C4C3)C=3C=CC(OCC=4C=C(Cl)C(Cl)=CC=4)=CC=3)C(=O)C=3C=CC=CC=3)C(O)=O)=CC=2)=C1 JUPRHEXJQLPHQL-WRUZSIFFSA-N 0.000 description 2
- TYZJBCBRUMLMRT-DSMKTCEVSA-N (2s)-3-[4-(4-chlorophenyl)phenyl]-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(Cl)C=C1 TYZJBCBRUMLMRT-DSMKTCEVSA-N 0.000 description 2
- MJFQCGFYARRZQR-PPCQQBJASA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(5-methyl-1,2-oxazol-4-yl)methyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound O1N=CC(CN2C(CC3=CC=4OC[C@@H](OC=4C=C3C2)C=2C=CC(OCC=3C=C(Cl)C(Cl)=CC=3)=CC=2)C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C=CC(=CC=2)C#N)C(O)=O)=C1C MJFQCGFYARRZQR-PPCQQBJASA-N 0.000 description 2
- XFFBFTKFHQMKJT-DHUDCZEASA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-propan-2-yloxycarbonyl-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)C1CC2=CC=3OC[C@@H](OC=3C=C2CN1C(=O)OC(C)C)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 XFFBFTKFHQMKJT-DHUDCZEASA-N 0.000 description 2
- JRTOXOHRDWTBIU-ZKBZZPJSSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylbutyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CCC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 JRTOXOHRDWTBIU-ZKBZZPJSSA-N 0.000 description 2
- ZJUUUAXTJOTBPG-ZTAAISNPSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 ZJUUUAXTJOTBPG-ZTAAISNPSA-N 0.000 description 2
- SDEAGACSNFSZCU-UHFFFAOYSA-N (3-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(Cl)=C1 SDEAGACSNFSZCU-UHFFFAOYSA-N 0.000 description 2
- XILDFUDDNSNLIF-HKGQQODZSA-N (3R,8S)-8-[[(2S)-3-[4-(4-cyanophenyl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2H-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylic acid Chemical compound C(#N)C1=CC=C(C=C1)C1=CC=C(C=C1)C[C@@H](C(=O)OC)NC(=O)[C@H]1N(CC=2C=C3C(=CC=2C1)OC[C@H](O3)C1=CC=C(C=C1)OCC1=CC(=C(C=C1)Cl)Cl)C(=O)O XILDFUDDNSNLIF-HKGQQODZSA-N 0.000 description 2
- UIPNPFUNPXYKGP-UHFFFAOYSA-N (3S)-6,7-Dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid Natural products OC1=C(O)C=C2CNC(C(=O)O)CC2=C1 UIPNPFUNPXYKGP-UHFFFAOYSA-N 0.000 description 2
- SQRGFKDNKOISFZ-SVNIRARHSA-N (3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-1-methyl-7-[(2-methylpropan-2-yl)oxycarbonyl]-3,6,8,9-tetrahydro-2h-pyrido[4,3-g][1,4]benzoxazine-8-carboxylic acid Chemical compound C1=CC([C@H]2CN(C3=CC=4CC(N(CC=4C=C3O2)C(=O)OC(C)(C)C)C(O)=O)C)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 SQRGFKDNKOISFZ-SVNIRARHSA-N 0.000 description 2
- UIPNPFUNPXYKGP-ZETCQYMHSA-N (3s)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid Chemical compound OC1=C(O)C=C2CN[C@H](C(=O)O)CC2=C1 UIPNPFUNPXYKGP-ZETCQYMHSA-N 0.000 description 2
- ABYPRALCFKJRCP-ZETCQYMHSA-N (3s)-6,7-dihydroxy-3,4-dihydro-1h-isoquinoline-2,3-dicarboxylic acid Chemical compound OC1=C(O)C=C2CN(C(O)=O)[C@H](C(=O)O)CC2=C1 ABYPRALCFKJRCP-ZETCQYMHSA-N 0.000 description 2
- IIKGZTHZDODFSU-QMMMGPOBSA-N (3s)-7-hydroxy-6-nitro-3,4-dihydro-1h-isoquinoline-2,3-dicarboxylic acid Chemical compound [O-][N+](=O)C1=C(O)C=C2CN(C(O)=O)[C@H](C(=O)O)CC2=C1 IIKGZTHZDODFSU-QMMMGPOBSA-N 0.000 description 2
- QHSXSZKLFNISFX-RPLLCQBOSA-N (3s,8s)-3-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(2-methylpropan-2-yl)oxycarbonyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C=1C([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(O)=O)C(=O)OC(C)(C)C)=CC=CC=1OCC1=CC=C(Cl)C(Cl)=C1 QHSXSZKLFNISFX-RPLLCQBOSA-N 0.000 description 2
- GDXUAHDIEBAHTP-LYVYPOQBSA-N (3s,8s)-3-[4-(cyclopentylmethoxy)phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C1=CC([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(O)=O)[C@@H](CC)C=2C=CC=CC=2)=CC=C1OCC1CCCC1 GDXUAHDIEBAHTP-LYVYPOQBSA-N 0.000 description 2
- XYHIWUWOCXFFNO-YLJHYDRVSA-N (3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1r)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C1=CC([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(O)=O)[C@H](CC)C=2C=CC=CC=2)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 XYHIWUWOCXFFNO-YLJHYDRVSA-N 0.000 description 2
- XJMLYFZJZOKSFP-WSZLSEGOSA-N (3s,8s)-3-[4-[(3-chlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C1=CC([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(O)=O)[C@@H](CC)C=2C=CC=CC=2)=CC=C1OCC1=CC=CC(Cl)=C1 XJMLYFZJZOKSFP-WSZLSEGOSA-N 0.000 description 2
- CEBAHYWORUOILU-UHFFFAOYSA-N (4-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=C(C#N)C=C1 CEBAHYWORUOILU-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 description 2
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical group CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 2
- ACIZMRQNCPNDGU-UHFFFAOYSA-N 1-[3-[(3,4-dichlorophenyl)methoxy]phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=C1 ACIZMRQNCPNDGU-UHFFFAOYSA-N 0.000 description 2
- VUWLYIRUBZGJJB-UHFFFAOYSA-N 1-[4-[(3,4-dichlorophenyl)methoxy]phenyl]ethane-1,2-diol Chemical compound C1=CC(C(O)CO)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 VUWLYIRUBZGJJB-UHFFFAOYSA-N 0.000 description 2
- GEKQPJHLFWEGPX-UHFFFAOYSA-N 1-[4-[(3,4-dichlorophenyl)methoxy]phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 GEKQPJHLFWEGPX-UHFFFAOYSA-N 0.000 description 2
- OTRZIEWHELCVJX-UHFFFAOYSA-N 1-methoxy-2-(2-methoxyethoxy)ethane;1-methylpyrrolidin-2-one Chemical compound CN1CCCC1=O.COCCOCCOC OTRZIEWHELCVJX-UHFFFAOYSA-N 0.000 description 2
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 2
- KFEWUCOFCOAYQZ-UHFFFAOYSA-N 2,5-dimethyl-1-oxidopyridin-1-ium Chemical compound CC1=CC=C(C)[N+]([O-])=C1 KFEWUCOFCOAYQZ-UHFFFAOYSA-N 0.000 description 2
- GVGSFHVUBRWBJT-UHFFFAOYSA-N 2,5-dimethyl-4-nitro-1-oxidopyridin-1-ium Chemical compound CC1=C[N+]([O-])=C(C)C=C1[N+]([O-])=O GVGSFHVUBRWBJT-UHFFFAOYSA-N 0.000 description 2
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2,5-dimethylpyridine Chemical compound CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 2
- MTMONFVFAYLRSG-UHFFFAOYSA-N 2-(4-hydroxyphenyl)-2-oxoacetaldehyde Chemical compound OC1=CC=C(C(=O)C=O)C=C1 MTMONFVFAYLRSG-UHFFFAOYSA-N 0.000 description 2
- XHGSCBXRKVMCDO-UHFFFAOYSA-N 2-bromo-1-[3-[(3,4-dichlorophenyl)methoxy]phenyl]ethanone Chemical compound C1=C(Cl)C(Cl)=CC=C1COC1=CC=CC(C(=O)CBr)=C1 XHGSCBXRKVMCDO-UHFFFAOYSA-N 0.000 description 2
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 2
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 2
- YMPDUCFKKPWPSU-UHFFFAOYSA-N 2-methyl-6-(methylamino)pyridine-3-sulfonyl chloride Chemical compound CNC1=CC=C(S(Cl)(=O)=O)C(C)=N1 YMPDUCFKKPWPSU-UHFFFAOYSA-N 0.000 description 2
- 125000004135 2-norbornyl group Chemical group [H]C1([H])C([H])([H])C2([H])C([H])([H])C1([H])C([H])([H])C2([H])* 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 2
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 2
- WUQBOLHUTUTBDT-NRFANRHFSA-N 3-[(2r)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2-hydroxyethoxy]-4-fluorobenzonitrile Chemical compound C([C@H](O)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)OC1=CC(C#N)=CC=C1F WUQBOLHUTUTBDT-NRFANRHFSA-N 0.000 description 2
- QEMJYKLHEHHODB-OAQYLSRUSA-N 3-[(2s)-2-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-2-hydroxyethoxy]-4-fluorobenzonitrile Chemical compound C([C@@H](O)C=1C=C(OCC=2C=C(Cl)C(Cl)=CC=2)C=CC=1)OC1=CC(C#N)=CC=C1F QEMJYKLHEHHODB-OAQYLSRUSA-N 0.000 description 2
- WUQBOLHUTUTBDT-OAQYLSRUSA-N 3-[(2s)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2-hydroxyethoxy]-4-fluorobenzonitrile Chemical compound C([C@@H](O)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)OC1=CC(C#N)=CC=C1F WUQBOLHUTUTBDT-OAQYLSRUSA-N 0.000 description 2
- HJSZIXHADLYANW-UHFFFAOYSA-N 3-[2-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-2-oxoethoxy]-4-fluorobenzonitrile Chemical compound FC1=CC=C(C#N)C=C1OCC(=O)C1=CC=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=C1 HJSZIXHADLYANW-UHFFFAOYSA-N 0.000 description 2
- BJDIYRQSJLBFLX-UHFFFAOYSA-N 3-[2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2-oxoethoxy]-4-fluorobenzonitrile Chemical compound FC1=CC=C(C#N)C=C1OCC(=O)C(C=C1)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 BJDIYRQSJLBFLX-UHFFFAOYSA-N 0.000 description 2
- XMZQWZJMTBCUFT-UHFFFAOYSA-N 3-bromopropylbenzene Chemical compound BrCCCC1=CC=CC=C1 XMZQWZJMTBCUFT-UHFFFAOYSA-N 0.000 description 2
- LUJMEECXHPYQOF-UHFFFAOYSA-N 3-hydroxyacetophenone Chemical compound CC(=O)C1=CC=CC(O)=C1 LUJMEECXHPYQOF-UHFFFAOYSA-N 0.000 description 2
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- CGPIONYVXKQZPW-UHFFFAOYSA-N 4-bromo-2,5-dimethylpyridine Chemical compound CC1=CC(Br)=C(C)C=N1 CGPIONYVXKQZPW-UHFFFAOYSA-N 0.000 description 2
- TVRGNBFSOZCSSE-UHFFFAOYSA-N 4-bromo-2-ethylpyridine Chemical compound CCC1=CC(Br)=CC=N1 TVRGNBFSOZCSSE-UHFFFAOYSA-N 0.000 description 2
- LKTBMKIXEOGAGF-UHFFFAOYSA-N 4-fluoro-3-hydroxybenzonitrile Chemical compound OC1=CC(C#N)=CC=C1F LKTBMKIXEOGAGF-UHFFFAOYSA-N 0.000 description 2
- LTPVSOCPYWDIFU-UHFFFAOYSA-N 4-methoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1 LTPVSOCPYWDIFU-UHFFFAOYSA-N 0.000 description 2
- KRNSYSYRLQDHDK-UHFFFAOYSA-N 6,7-dihydro-5h-cyclopenta[b]pyridine Chemical compound C1=CN=C2CCCC2=C1 KRNSYSYRLQDHDK-UHFFFAOYSA-N 0.000 description 2
- VEMRABIYJBLARI-UHFFFAOYSA-N 6-(cyclopropylmethylamino)-2-methylpyridine-3-sulfonyl chloride Chemical compound C1=C(S(Cl)(=O)=O)C(C)=NC(NCC2CC2)=C1 VEMRABIYJBLARI-UHFFFAOYSA-N 0.000 description 2
- QXDWGEGBDGGNNW-UHFFFAOYSA-N 6-acetamido-2-methylpyridine-3-sulfonyl chloride Chemical compound CC(=O)NC1=CC=C(S(Cl)(=O)=O)C(C)=N1 QXDWGEGBDGGNNW-UHFFFAOYSA-N 0.000 description 2
- ZWADNRXQZKMSKZ-UHFFFAOYSA-N 6-acetamido-4-methylpyridine-3-sulfonyl chloride Chemical compound CC(=O)NC1=CC(C)=C(S(Cl)(=O)=O)C=N1 ZWADNRXQZKMSKZ-UHFFFAOYSA-N 0.000 description 2
- 125000004136 7-norbornyl group Chemical group [H]C1([H])C([H])([H])C2([H])C([H])([H])C([H])([H])C1([H])C2([H])* 0.000 description 2
- SXZAJJPHAKPDGL-ZBAATNBSSA-N 7-o-tert-butyl 8-o-methyl (3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-1-methyl-3,6,8,9-tetrahydro-2h-pyrido[4,3-g][1,4]benzoxazine-7,8-dicarboxylate Chemical compound C1=CC([C@H]2CN(C)C=3C=C4CC(N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 SXZAJJPHAKPDGL-ZBAATNBSSA-N 0.000 description 2
- RNERNOZXQRPVHP-LDCRUHPQSA-N 7-o-tert-butyl 8-o-methyl (3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3-hydroxy-2,6,8,9-tetrahydro-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C1=CC([C@@]2(O)COC=3C=C4CC(N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 RNERNOZXQRPVHP-LDCRUHPQSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- HYTRYEXINDDXJK-UHFFFAOYSA-N Ethyl isopropyl ketone Chemical compound CCC(=O)C(C)C HYTRYEXINDDXJK-UHFFFAOYSA-N 0.000 description 2
- 229940089838 Glucagon-like peptide 1 receptor agonist Drugs 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 238000006751 Mitsunobu reaction Methods 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 238000006929 Pictet-Spengler synthesis reaction Methods 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 125000003670 adamantan-2-yl group Chemical group [H]C1([H])C(C2([H])[H])([H])C([H])([H])C3([H])C([*])([H])C1([H])C([H])([H])C2([H])C3([H])[H] 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000000732 arylene group Chemical group 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 2
- FLHFTXCMKFVKRP-UHFFFAOYSA-N bromomethylcyclobutane Chemical compound BrCC1CCC1 FLHFTXCMKFVKRP-UHFFFAOYSA-N 0.000 description 2
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- JUFFVKRROAPVBI-PVOYSMBESA-N chembl1210015 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N[C@H]1[C@@H]([C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@]3(O[C@@H](C[C@H](O)[C@H](O)CO)[C@H](NC(C)=O)[C@@H](O)C3)C(O)=O)O2)O)[C@@H](CO)O1)NC(C)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 JUFFVKRROAPVBI-PVOYSMBESA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229940076286 cupric acetate Drugs 0.000 description 2
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- 125000004956 cyclohexylene group Chemical group 0.000 description 2
- 125000004980 cyclopropylene group Chemical group 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000010931 ester hydrolysis Methods 0.000 description 2
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 2
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229960001519 exenatide Drugs 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 125000004438 haloalkoxy group Chemical group 0.000 description 2
- 125000005549 heteroarylene group Chemical group 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- DUMSKQUKLVSSII-UHFFFAOYSA-N iodomethylcyclopentane Chemical compound ICC1CCCC1 DUMSKQUKLVSSII-UHFFFAOYSA-N 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001786 isothiazolyl group Chemical group 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- IVDOIYGHPJPXFO-PKLMIRHRSA-N methyl (2r)-2-amino-3-[4-(4-cyanophenyl)phenyl]propanoate;hydrochloride Chemical compound Cl.C1=CC(C[C@@H](N)C(=O)OC)=CC=C1C1=CC=C(C#N)C=C1 IVDOIYGHPJPXFO-PKLMIRHRSA-N 0.000 description 2
- GTPSYWNNEXIAGW-HKGQQODZSA-N methyl (2s)-2-[[(3r,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=NC(C)=C1C GTPSYWNNEXIAGW-HKGQQODZSA-N 0.000 description 2
- MQZCTAVTLPFULC-VEBFQCSLSA-N methyl (2s)-2-[[(3s)-1-acetyl-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydropyrido[4,3-g][1,4]benzoxazine-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoate;hydrochloride Chemical compound Cl.C([C@@H](C(=O)OC)NC(=O)C1NCC2=CC=3O[C@H](CN(C=3C=C2C1)C(C)=O)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 MQZCTAVTLPFULC-VEBFQCSLSA-N 0.000 description 2
- IUWQRTYGNBILBK-KXIZWUBZSA-N methyl (2s)-2-[[(3s)-3-[4-[(3-chloro-4-methylphenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoate;hydrochloride Chemical compound Cl.C([C@@H](C(=O)OC)NC(=O)C1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(C)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 IUWQRTYGNBILBK-KXIZWUBZSA-N 0.000 description 2
- VICBVLZLISVDCT-VHYZKNOSSA-N methyl (2s)-2-[[(3s,8s)-3-[4-(3-chlorophenoxy)phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OC=2C=C(Cl)C=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=NC(C)=C1C VICBVLZLISVDCT-VHYZKNOSSA-N 0.000 description 2
- XWNBUFPRJYNESG-VHYZKNOSSA-N methyl (2s)-2-[[(3s,8s)-3-[4-(3-chlorophenyl)phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(=CC=1)C=1C=C(Cl)C=CC=1)C(C=C1)=CC=C1C1=CC=NC(C)=C1C XWNBUFPRJYNESG-VHYZKNOSSA-N 0.000 description 2
- BRUKMUWDWWPPBM-IIRRWZJPSA-N methyl (2s)-2-[[(3s,8s)-3-[4-(cyclohexylmethoxy)phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)oxyphenyl]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC2CCCCC2)=CC=1)C(C=C1)=CC=C1OC1=CC=NC(C)=C1C BRUKMUWDWWPPBM-IIRRWZJPSA-N 0.000 description 2
- RIPOSSZLZQIYOB-YLJLHNITSA-N methyl (2s)-2-[[(3s,8s)-3-[4-(cyclohexylmethoxy)phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC2CCCCC2)=CC=1)C(C=C1)=CC=C1C1=CC=NC(C)=C1C RIPOSSZLZQIYOB-YLJLHNITSA-N 0.000 description 2
- HMKJGFLHCXAJFP-CKUXDGONSA-N methyl (2s)-2-amino-3-[4-(2-methylpyridin-4-yl)oxyphenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1OC1=CC=NC(C)=C1 HMKJGFLHCXAJFP-CKUXDGONSA-N 0.000 description 2
- QWJMMNXUOBFQLN-RSAXXLAASA-N methyl (2s)-2-amino-3-[4-(4-chlorophenyl)phenyl]propanoate;hydrochloride Chemical compound Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(Cl)C=C1 QWJMMNXUOBFQLN-RSAXXLAASA-N 0.000 description 2
- ZPGYXIVFYCKLQK-SFHVURJKSA-N methyl (2s)-2-amino-3-[4-(4-cyanophenyl)phenyl]-2-methylpropanoate Chemical compound C1=CC(C[C@](C)(N)C(=O)OC)=CC=C1C1=CC=C(C#N)C=C1 ZPGYXIVFYCKLQK-SFHVURJKSA-N 0.000 description 2
- VRRRLQSVWDNHDW-RSAXXLAASA-N methyl (2s)-2-amino-3-[4-(4-fluorophenyl)phenyl]propanoate;hydrochloride Chemical compound Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(F)C=C1 VRRRLQSVWDNHDW-RSAXXLAASA-N 0.000 description 2
- ZLCHSICIKWGTID-CKUXDGONSA-N methyl (2s)-2-amino-3-[4-[2-(fluoromethyl)pyridin-4-yl]phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC(CF)=C1 ZLCHSICIKWGTID-CKUXDGONSA-N 0.000 description 2
- JMUQVEFMAXSRQF-ZOWNYOTGSA-N methyl (2s)-2-amino-3-[5-(4-cyanophenyl)thiophen-2-yl]propanoate;hydrochloride Chemical compound Cl.S1C(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(C#N)C=C1 JMUQVEFMAXSRQF-ZOWNYOTGSA-N 0.000 description 2
- NQIFXJSLCUJHBB-LBPRGKRZSA-N methyl (2s)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound CC(C)(C)OC(=O)N[C@H](C(=O)OC)CC1=CC=C(O)C=C1 NQIFXJSLCUJHBB-LBPRGKRZSA-N 0.000 description 2
- AGWKPQQUZAALHO-IBGZPJMESA-N methyl (2s)-3-(4-hydroxyphenyl)-2-methyl-2-(phenylmethoxycarbonylamino)propanoate Chemical compound C([C@@](C)(C(=O)OC)NC(=O)OCC=1C=CC=CC=1)C1=CC=C(O)C=C1 AGWKPQQUZAALHO-IBGZPJMESA-N 0.000 description 2
- JQPPZFDAUFVJIL-VIFPVBQESA-N methyl (2s)-3-(5-bromothiophen-2-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound CC(C)(C)OC(=O)N[C@H](C(=O)OC)CC1=CC=C(Br)S1 JQPPZFDAUFVJIL-VIFPVBQESA-N 0.000 description 2
- DNAFOSMJBHMVEX-IGKIAQTJSA-N methyl (2s)-3-[(2r)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound C1=CC([C@H]2OC3=CC=C(C=C3OC2)C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 DNAFOSMJBHMVEX-IGKIAQTJSA-N 0.000 description 2
- FHUMOBVHYICPOI-FIBWVYCGSA-N methyl (2s)-3-[(2r)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(4-nitrophenyl)sulfonylamino]propanoate Chemical compound C1=CC([C@H]2OC3=CC=C(C=C3OC2)C[C@@H](C(=O)OC)NS(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 FHUMOBVHYICPOI-FIBWVYCGSA-N 0.000 description 2
- PPAPOWBYYFKEST-NGCAANIMSA-N methyl (2s)-3-[(2r)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[[(1s)-1-phenylpropyl]amino]propanoate Chemical compound C1=CC([C@H]2OC3=CC=C(C=C3OC2)C[C@H](N[C@@H](CC)C=2C=CC=CC=2)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 PPAPOWBYYFKEST-NGCAANIMSA-N 0.000 description 2
- OGDLZKANMRDWRF-PNIUZAESSA-N methyl (2s)-3-[(2s)-2-(4-acetyloxyphenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[[(1s)-1-phenylpropyl]amino]propanoate Chemical compound C1([C@@H]2OC3=CC=C(C=C3OC2)C[C@H](N[C@@H](CC)C=2C=CC=CC=2)C(=O)OC)=CC=C(OC(C)=O)C=C1 OGDLZKANMRDWRF-PNIUZAESSA-N 0.000 description 2
- XMDDUGULQPUMIB-JCYRPKCISA-N methyl (2s)-3-[(2s)-2-(4-hydroxyphenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[[(1s)-1-phenylpropyl]amino]propanoate Chemical compound C1([C@@H]2OC3=CC=C(C=C3OC2)C[C@H](N[C@@H](CC)C=2C=CC=CC=2)C(=O)OC)=CC=C(O)C=C1 XMDDUGULQPUMIB-JCYRPKCISA-N 0.000 description 2
- FVLLSXQHLDNFST-VHYZKNOSSA-N methyl (2s)-3-[(2s)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(4-nitrophenyl)sulfonyl-[(1s)-1-phenylpropyl]amino]propanoate Chemical compound C1=CC([C@@H]2OC3=CC=C(C=C3OC2)C[C@H](N([C@@H](CC)C=2C=CC=CC=2)S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 FVLLSXQHLDNFST-VHYZKNOSSA-N 0.000 description 2
- FHUMOBVHYICPOI-BHBYDHKZSA-N methyl (2s)-3-[(2s)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(4-nitrophenyl)sulfonylamino]propanoate Chemical compound C1=CC([C@@H]2OC3=CC=C(C=C3OC2)C[C@@H](C(=O)OC)NS(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 FHUMOBVHYICPOI-BHBYDHKZSA-N 0.000 description 2
- PPAPOWBYYFKEST-YLJHYDRVSA-N methyl (2s)-3-[(2s)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[[(1r)-1-phenylpropyl]amino]propanoate Chemical compound C1=CC([C@@H]2OC3=CC=C(C=C3OC2)C[C@H](N[C@H](CC)C=2C=CC=CC=2)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 PPAPOWBYYFKEST-YLJHYDRVSA-N 0.000 description 2
- LXOYICPHPKAIRO-YDNXMHBPSA-N methyl (2s)-3-[2-(4-acetyloxyphenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound C1OC2=CC(C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C2OC1C1=CC=C(OC(C)=O)C=C1 LXOYICPHPKAIRO-YDNXMHBPSA-N 0.000 description 2
- YLBJCHJGSFAUQU-UCFFOFKASA-N methyl (2s)-3-[2-(4-acetyloxyphenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2-aminopropanoate Chemical compound C1OC2=CC(C[C@H](N)C(=O)OC)=CC=C2OC1C1=CC=C(OC(C)=O)C=C1 YLBJCHJGSFAUQU-UCFFOFKASA-N 0.000 description 2
- DNAFOSMJBHMVEX-BXXZMZEQSA-N methyl (2s)-3-[2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound C1OC2=CC(C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C2OC1C(C=C1)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 DNAFOSMJBHMVEX-BXXZMZEQSA-N 0.000 description 2
- OSUIIODYUWFPJK-PVCWFJFTSA-N methyl (2s)-3-[3-bromo-4-[1-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2-hydroxyethoxy]phenyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound BrC1=CC(C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1OC(CO)C(C=C1)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 OSUIIODYUWFPJK-PVCWFJFTSA-N 0.000 description 2
- CXDVNMQGZJJDLH-UJGAEZNTSA-N methyl (2s)-3-[3-bromo-4-[2-[tert-butyl(diphenyl)silyl]oxy-1-[4-[(3,4-dichlorophenyl)methoxy]phenyl]ethoxy]phenyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound BrC1=CC(C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1OC(C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)CO[Si](C(C)(C)C)(C=1C=CC=CC=1)C1=CC=CC=C1 CXDVNMQGZJJDLH-UJGAEZNTSA-N 0.000 description 2
- MCSRCZOMLYENHO-IBGZPJMESA-N methyl (2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound C1=CC(C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1C1=CC=NC(C)=C1C MCSRCZOMLYENHO-IBGZPJMESA-N 0.000 description 2
- GOUWLKGRUODXDV-IBGZPJMESA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound C1=CC(C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1C1=CC=C(C#N)C=C1 GOUWLKGRUODXDV-IBGZPJMESA-N 0.000 description 2
- COEKCZCWLCNZBB-HKGQQODZSA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3r,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 COEKCZCWLCNZBB-HKGQQODZSA-N 0.000 description 2
- SBRJJILRBNATLO-TXSBWBSASA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-1-methyl-2,3,6,7,8,9-hexahydropyrido[4,3-g][1,4]benzoxazine-8-carbonyl]amino]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)C1NCC2=CC=3O[C@H](CN(C)C=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 SBRJJILRBNATLO-TXSBWBSASA-N 0.000 description 2
- CSFRLQBHXIFSIG-VEBFQCSLSA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dimethylphenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate;hydrochloride Chemical compound Cl.C([C@@H](C(=O)OC)NC(=O)C1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(C)C(C)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 CSFRLQBHXIFSIG-VEBFQCSLSA-N 0.000 description 2
- OGBLFWFWYDAKSZ-INIZCTEOSA-N methyl (2s)-3-[5-(4-cyanophenyl)thiophen-2-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound S1C(C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1C1=CC=C(C#N)C=C1 OGBLFWFWYDAKSZ-INIZCTEOSA-N 0.000 description 2
- AVDQGIMBHNKULH-NLJOTIRTSA-N methyl (3s,8s)-3-(4-hydroxyphenyl)-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylate Chemical compound C1([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(=O)OC)[C@@H](CC)C=2C=CC=CC=2)=CC=C(O)C=C1 AVDQGIMBHNKULH-NLJOTIRTSA-N 0.000 description 2
- ZQZFFJHCMLLJGF-HHHXNRCGSA-N methyl 3-[(2s)-2-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]prop-2-enoate Chemical compound C=1C([C@@H]2OC3=CC=C(C=C3OC2)C=C(NC(=O)OC(C)(C)C)C(=O)OC)=CC=CC=1OCC1=CC=C(Cl)C(Cl)=C1 ZQZFFJHCMLLJGF-HHHXNRCGSA-N 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- IVBVDGOVRUPPAU-UHFFFAOYSA-N n,6-dimethyl-5-nitropyridin-2-amine Chemical compound CNC1=CC=C([N+]([O-])=O)C(C)=N1 IVBVDGOVRUPPAU-UHFFFAOYSA-N 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical group CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 125000002098 pyridazinyl group Chemical group 0.000 description 2
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 2
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 2
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 238000006277 sulfonation reaction Methods 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical class S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 description 2
- 229910052815 sulfur oxide Inorganic materials 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- YZPVIRDQSFKCJS-RNMNAOLMSA-N tert-butyl (3r,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-8-[[(2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1N(CC2=CC=3O[C@@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1C1=CC=NC(C)=C1C YZPVIRDQSFKCJS-RNMNAOLMSA-N 0.000 description 2
- VWTNSISTYUPFBH-IWJNXRQDSA-N tert-butyl (3s,8s)-3-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-8-[[(2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=C(OCC=2C=C(Cl)C(Cl)=CC=2)C=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1C1=CC=NC(C)=C1C VWTNSISTYUPFBH-IWJNXRQDSA-N 0.000 description 2
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical compound CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 2
- XMXIFYUQKOMUJR-UHFFFAOYSA-N tert-butyl n-[5-(bromomethyl)-4-methyl-1,3-thiazol-2-yl]carbamate Chemical compound CC=1N=C(NC(=O)OC(C)(C)C)SC=1CBr XMXIFYUQKOMUJR-UHFFFAOYSA-N 0.000 description 2
- JKBGHFXEMZZLFY-UHFFFAOYSA-N tert-butyl n-[5-(bromomethyl)pyridin-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=C(CBr)C=N1 JKBGHFXEMZZLFY-UHFFFAOYSA-N 0.000 description 2
- IUKJGZQDJHHXDK-UHFFFAOYSA-N tert-butyl n-[5-(hydroxymethyl)-4-methyl-1,3-thiazol-2-yl]carbamate Chemical compound CC=1N=C(NC(=O)OC(C)(C)C)SC=1CO IUKJGZQDJHHXDK-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- HQRWWHIETAKIMO-SNVBAGLBSA-N (1r)-1-phenylbutan-1-ol Chemical compound CCC[C@@H](O)C1=CC=CC=C1 HQRWWHIETAKIMO-SNVBAGLBSA-N 0.000 description 1
- BUDRXDXIUACVTR-QFIPXVFZSA-N (2r)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxine-6-carbaldehyde Chemical compound C1=C(Cl)C(Cl)=CC=C1COC1=CC=C([C@H]2OC3=CC=C(C=O)C=C3OC2)C=C1 BUDRXDXIUACVTR-QFIPXVFZSA-N 0.000 description 1
- ZQEBQGAAWMOMAI-ZETCQYMHSA-N (2s)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CCC[C@H]1C(O)=O ZQEBQGAAWMOMAI-ZETCQYMHSA-N 0.000 description 1
- SQECZMJJIUCWKE-WRKASMAWSA-N (2s)-2-[[(3s)-1-acetyl-7-benzoyl-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-pyrido[4,3-g][1,4]benzoxazine-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)C1N(CC=2C=C3O[C@H](CN(C3=CC=2C1)C(=O)C)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C=1C=CC=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 SQECZMJJIUCWKE-WRKASMAWSA-N 0.000 description 1
- YRVXPRAJBJCWNM-SIORXBAWSA-N (2s)-2-[[(3s)-7-(2-chlorobenzoyl)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C=1C(=CC=CC=1)Cl)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 YRVXPRAJBJCWNM-SIORXBAWSA-N 0.000 description 1
- UMWOCGDGIRGQRL-NRDMTTIESA-N (2s)-2-[[(3s)-7-(4-acetamidophenyl)sulfonyl-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C1=CC(NC(=O)C)=CC=C1S(=O)(=O)N1C(C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C=CC(=CC=2)C#N)C(O)=O)CC2=CC(OC[C@@H](O3)C=4C=CC(OCC=5C=C(Cl)C(Cl)=CC=5)=CC=4)=C3C=C2C1 UMWOCGDGIRGQRL-NRDMTTIESA-N 0.000 description 1
- ANSZCEZIDJYVLD-YUTPAWSZSA-N (2s)-2-[[(3s)-7-[(2-amino-1,3-thiazol-5-yl)sulfonyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound S1C(N)=NC=C1S(=O)(=O)N1C(C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C=CC(=CC=2)C#N)C(O)=O)CC2=CC(OC[C@@H](O3)C=4C=CC(OCC=5C=C(Cl)C(Cl)=CC=5)=CC=4)=C3C=C2C1 ANSZCEZIDJYVLD-YUTPAWSZSA-N 0.000 description 1
- IJJGULDXVBWFMH-LLSVSLFMSA-N (2s)-2-[[(3s)-7-[(2-chloro-6-fluorophenyl)methyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)CC=1C(=CC=CC=1F)Cl)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 IJJGULDXVBWFMH-LLSVSLFMSA-N 0.000 description 1
- BMHMWUGFHPAUBO-LLSVSLFMSA-N (2s)-2-[[(3s)-7-[(2-chlorophenyl)methyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)CC=1C(=CC=CC=1)Cl)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 BMHMWUGFHPAUBO-LLSVSLFMSA-N 0.000 description 1
- DMWQFXVWOFZMDC-NRDMTTIESA-N (2s)-2-[[(3s)-7-[(2-cyanophenyl)methyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)CC=1C(=CC=CC=1)C#N)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 DMWQFXVWOFZMDC-NRDMTTIESA-N 0.000 description 1
- BWHBEKAUPGCKNA-LLSVSLFMSA-N (2s)-2-[[(3s)-7-benzyl-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)CC=1C=CC=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 BWHBEKAUPGCKNA-LLSVSLFMSA-N 0.000 description 1
- KVVGVRCAGXLJRL-XSBWBPONSA-N (2s)-2-[[(3s)-7-but-2-ynoxycarbonyl-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(4-cyanophenyl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)C1CC2=CC=3OC[C@@H](OC=3C=C2CN1C(=O)OCC#CC)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 KVVGVRCAGXLJRL-XSBWBPONSA-N 0.000 description 1
- ORVIXSAPJXWSAV-DSMKTCEVSA-N (2s)-2-[[(3s,8s)-3-(4-cyclohexyloxyphenyl)-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OC2CCCCC2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C ORVIXSAPJXWSAV-DSMKTCEVSA-N 0.000 description 1
- LIRITKFHAYJRMK-WWKIHPBISA-N (2s)-2-[[(3s,8s)-3-(4-cyclopentyloxyphenyl)-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OC2CCCC2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C LIRITKFHAYJRMK-WWKIHPBISA-N 0.000 description 1
- UDIWNRGEFHPODU-VQRUSENYSA-N (2s)-2-[[(3s,8s)-3-[4-(3-chlorophenoxy)phenyl]-7-(2,5-dimethyl-1,3-oxazole-4-carbonyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound O1C(C)=NC(C(=O)N2[C@@H](CC3=CC=4OC[C@@H](OC=4C=C3C2)C=2C=CC(OC=3C=C(Cl)C=CC=3)=CC=2)C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C(=C(C)N=CC=2)C)C(O)=O)=C1C UDIWNRGEFHPODU-VQRUSENYSA-N 0.000 description 1
- TZOOEQWPQASMBH-VQRUSENYSA-N (2s)-2-[[(3s,8s)-3-[4-(3-chlorophenyl)phenyl]-7-(2,5-dimethyl-1,3-oxazole-4-carbonyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound O1C(C)=NC(C(=O)N2[C@@H](CC3=CC=4OC[C@@H](OC=4C=C3C2)C=2C=CC(=CC=2)C=2C=C(Cl)C=CC=2)C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C(=C(C)N=CC=2)C)C(O)=O)=C1C TZOOEQWPQASMBH-VQRUSENYSA-N 0.000 description 1
- BNUFTAKJIDKGNT-ZTAAISNPSA-N (2s)-2-[[(3s,8s)-3-[4-(cyclohexylmethoxy)phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC2CCCCC2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C BNUFTAKJIDKGNT-ZTAAISNPSA-N 0.000 description 1
- KRTUZUQQOGGJLI-IWJNXRQDSA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(2,5-dimethyl-1,3-oxazole-4-carbonyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound O1C(C)=NC(C(=O)N2[C@@H](CC3=CC=4OC[C@@H](OC=4C=C3C2)C=2C=CC(OCC=3C=C(Cl)C(Cl)=CC=3)=CC=2)C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C(=C(C)N=CC=2)C)C(O)=O)=C1C KRTUZUQQOGGJLI-IWJNXRQDSA-N 0.000 description 1
- GLDWINJLFVTQNO-VQRUSENYSA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(2-methylpropanoyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1C(=O)C(C)C)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C GLDWINJLFVTQNO-VQRUSENYSA-N 0.000 description 1
- XXXHGAXRCNAYKZ-UWFQYGBDSA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(2-phenylacetyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound CC1=NC=CC(C=2C=CC(C[C@H](NC(=O)[C@H]3N(CC4=CC=5O[C@H](COC=5C=C4C3)C=3C=CC(OCC=4C=C(Cl)C(Cl)=CC=4)=CC=3)C(=O)CC=3C=CC=CC=3)C(O)=O)=CC=2)=C1C XXXHGAXRCNAYKZ-UWFQYGBDSA-N 0.000 description 1
- ITRIHRNIJPFRBN-YSBVQXAESA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-(4-pyridazin-4-ylphenyl)propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NN=C1 ITRIHRNIJPFRBN-YSBVQXAESA-N 0.000 description 1
- DSGPZERMCHZOFC-WWKIHPBISA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-(4-pyridin-3-yloxyphenyl)propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1OC1=CC=CN=C1 DSGPZERMCHZOFC-WWKIHPBISA-N 0.000 description 1
- UWHLJNJTFATDEI-WWKIHPBISA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-(4-pyridin-3-ylphenyl)propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=CN=C1 UWHLJNJTFATDEI-WWKIHPBISA-N 0.000 description 1
- AFWCGPRDQKWXQQ-WWKIHPBISA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-(4-pyridin-4-yloxyphenyl)propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1OC1=CC=NC=C1 AFWCGPRDQKWXQQ-WWKIHPBISA-N 0.000 description 1
- SWYCKRUNRBYFCY-YSBVQXAESA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-(4-pyrimidin-4-ylphenyl)propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC=N1 SWYCKRUNRBYFCY-YSBVQXAESA-N 0.000 description 1
- PWHKSISUWOVVCU-BPLXVOGRSA-N (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-(4-quinolin-4-ylphenyl)propanoic acid Chemical compound C1=CC([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C3=CC=CC=C3N=CC=2)C(O)=O)[C@@H](CC)C=2C=CC=CC=2)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 PWHKSISUWOVVCU-BPLXVOGRSA-N 0.000 description 1
- MWIHKJOXPIXUHD-KYUGQUBOSA-N (2s)-2-[[(3s,8s)-7-benzoyl-3-(4-hydroxyphenyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound CC1=NC=CC(C=2C=CC(C[C@H](NC(=O)[C@H]3N(CC4=CC=5O[C@H](COC=5C=C4C3)C=3C=CC(O)=CC=3)C(=O)C=3C=CC=CC=3)C(O)=O)=CC=2)=C1C MWIHKJOXPIXUHD-KYUGQUBOSA-N 0.000 description 1
- BUEWJCQCDQRXON-TVAVRQBESA-N (2s)-2-[[(3s,8s)-7-benzoyl-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid Chemical compound CC1=NC=CC(C=2C=CC(C[C@H](NC(=O)[C@H]3N(CC4=CC=5O[C@H](COC=5C=C4C3)C=3C=CC(OCC=4C=C(Cl)C(Cl)=CC=4)=CC=3)C(=O)C=3C=CC=CC=3)C(O)=O)=CC=2)=C1C BUEWJCQCDQRXON-TVAVRQBESA-N 0.000 description 1
- ULNOXUAEIPUJMK-NSHDSACASA-N (2s)-3-(4-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=C(Br)C=C1 ULNOXUAEIPUJMK-NSHDSACASA-N 0.000 description 1
- HHNNFRCLMQFXBA-QMMMGPOBSA-N (2s)-3-(5-bromothiophen-2-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=C(Br)S1 HHNNFRCLMQFXBA-QMMMGPOBSA-N 0.000 description 1
- FMKRVVVDUOECNS-FNFZQODSSA-N (2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-2-[[(3s,8s)-3-(4-ethoxyphenyl)-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C1=CC(OCC)=CC=C1[C@@H]1OC2=CC(CN([C@@H](C3)C(=O)N[C@@H](CC=4C=CC(=CC=4)C=4C(=C(C)N=CC=4)C)C(O)=O)[C@@H](CC)C=4C=CC=CC=4)=C3C=C2OC1 FMKRVVVDUOECNS-FNFZQODSSA-N 0.000 description 1
- RWORUGWZTDSQLW-IGVZRYHESA-N (2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-2-[[(3s,8s)-3-(4-hydroxyphenyl)-7-[(2-methylpropan-2-yl)oxycarbonyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound CC1=NC=CC(C=2C=CC(C[C@H](NC(=O)[C@H]3N(CC4=CC=5O[C@H](COC=5C=C4C3)C=3C=CC(O)=CC=3)C(=O)OC(C)(C)C)C(O)=O)=CC=2)=C1C RWORUGWZTDSQLW-IGVZRYHESA-N 0.000 description 1
- WQLZRHZSUWMMJQ-CNZZUQSYSA-N (2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-2-[[(3s,8s)-3-(4-methoxyphenyl)-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OC)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C WQLZRHZSUWMMJQ-CNZZUQSYSA-N 0.000 description 1
- BDXOBUMPXLYNSC-WWKIHPBISA-N (2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-2-[[(3s,8s)-3-(4-pentan-3-yloxyphenyl)-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C1=CC(OC(CC)CC)=CC=C1[C@@H]1OC2=CC(CN([C@@H](C3)C(=O)N[C@@H](CC=4C=CC(=CC=4)C=4C(=C(C)N=CC=4)C)C(O)=O)[C@@H](CC)C=4C=CC=CC=4)=C3C=C2OC1 BDXOBUMPXLYNSC-WWKIHPBISA-N 0.000 description 1
- MPENUVICSRASOD-ZTAAISNPSA-N (2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-2-[[(3s,8s)-3-(4-phenylmethoxyphenyl)-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC=2C=CC=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C MPENUVICSRASOD-ZTAAISNPSA-N 0.000 description 1
- GDQZHFMIDYNLGM-YSBVQXAESA-N (2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-2-[[(3s,8s)-3-[4-(2-methylpropoxy)phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OCC(C)C)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C GDQZHFMIDYNLGM-YSBVQXAESA-N 0.000 description 1
- KXNBQVBTARYAPT-NMGHVLOISA-N (2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-2-[[(3s,8s)-7-[(1s)-1-phenylpropyl]-3-(4-propan-2-yloxyphenyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)[C@@H]1CC2=CC=3OC[C@@H](OC=3C=C2CN1[C@@H](CC)C=1C=CC=CC=1)C=1C=CC(OC(C)C)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C KXNBQVBTARYAPT-NMGHVLOISA-N 0.000 description 1
- PBYKFQUJDVHITJ-SIORXBAWSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(2-methylsulfonylbenzoyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1C(=O)N1C(C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C=CC(=CC=2)C#N)C(O)=O)CC2=CC(OC[C@@H](O3)C=4C=CC(OCC=5C=C(Cl)C(Cl)=CC=5)=CC=4)=C3C=C2C1 PBYKFQUJDVHITJ-SIORXBAWSA-N 0.000 description 1
- NSUBDOAQQLVIMH-XSBWBPONSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(3-methylbutanoyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)C1CC2=CC=3OC[C@@H](OC=3C=C2CN1C(=O)CC(C)C)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 NSUBDOAQQLVIMH-XSBWBPONSA-N 0.000 description 1
- FUEWTSQUZDUBBJ-NRDMTTIESA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(3-phenylprop-2-ynoyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C#CC=1C=CC=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 FUEWTSQUZDUBBJ-NRDMTTIESA-N 0.000 description 1
- JLKOPQBMIMTEQZ-SIORXBAWSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(oxan-4-ylmethyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)CC1CCOCC1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 JLKOPQBMIMTEQZ-SIORXBAWSA-N 0.000 description 1
- PBOSJJXRTSTDIL-JYGRHXHISA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(oxolane-2-carbonyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C1OCCC1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 PBOSJJXRTSTDIL-JYGRHXHISA-N 0.000 description 1
- PDAGVQSSSILNAO-HBRKMURKSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(oxolane-3-carbonyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C1COCC1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 PDAGVQSSSILNAO-HBRKMURKSA-N 0.000 description 1
- UGQKNWAOBDBGEC-AZHBUCKTSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(pyrazine-2-carbonyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C=1N=CC=NC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 UGQKNWAOBDBGEC-AZHBUCKTSA-N 0.000 description 1
- YMLGANKWCDSYDT-DHUDCZEASA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(thiophene-2-carbonyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C=1SC=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 YMLGANKWCDSYDT-DHUDCZEASA-N 0.000 description 1
- ASDKMUIOKAYBEX-PPCQQBJASA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1-methylpyrazol-3-yl)methyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound CN1C=CC(CN2C(CC3=CC=4OC[C@@H](OC=4C=C3C2)C=2C=CC(OCC=3C=C(Cl)C(Cl)=CC=3)=CC=2)C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C=CC(=CC=2)C#N)C(O)=O)=N1 ASDKMUIOKAYBEX-PPCQQBJASA-N 0.000 description 1
- DUEOZWMHVORFFB-WLESTYKDSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(2-fluoro-6-methoxyphenyl)methyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound COC1=CC=CC(F)=C1CN1C(C(=O)N[C@@H](CC=2C=CC(=CC=2)C=2C=CC(=CC=2)C#N)C(O)=O)CC2=CC(OC[C@@H](O3)C=4C=CC(OCC=5C=C(Cl)C(Cl)=CC=5)=CC=4)=C3C=C2C1 DUEOZWMHVORFFB-WLESTYKDSA-N 0.000 description 1
- YYEVCNKQVKZUTH-SIORXBAWSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[2-(trifluoromethyl)benzoyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C=1C(=CC=CC=1)C(F)(F)F)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 YYEVCNKQVKZUTH-SIORXBAWSA-N 0.000 description 1
- VVIYBXRUKGBNOM-CCAUFTTCSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[[(1s)-1-phenylethyl]carbamoyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)C1CC2=CC=3OC[C@@H](OC=3C=C2CN1C(=O)N[C@@H](C)C=1C=CC=CC=1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 VVIYBXRUKGBNOM-CCAUFTTCSA-N 0.000 description 1
- KHULCJBLCDFJMU-KNGBNFTKSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-ethyl-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@H](NC(=O)C1CC2=CC=3OC[C@@H](OC=3C=C2CN1CC)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 KHULCJBLCDFJMU-KNGBNFTKSA-N 0.000 description 1
- PWDCXFZFGYNMMV-XSBWBPONSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-7-(cyclobutanecarbonyl)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C1CCC1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 PWDCXFZFGYNMMV-XSBWBPONSA-N 0.000 description 1
- VMAMFCIBYZMIAD-SIORXBAWSA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-7-(cyclohexanecarbonyl)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C1CCCCC1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 VMAMFCIBYZMIAD-SIORXBAWSA-N 0.000 description 1
- LERKHTRSWXJXHE-PPCQQBJASA-N (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-7-(cyclopentanecarbonyl)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)C1CCCC1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 LERKHTRSWXJXHE-PPCQQBJASA-N 0.000 description 1
- CWMONKPMDOKAFE-IWZUKJADSA-N (3S)-8-[[(2S)-3-[4-(4-cyanophenyl)phenyl]-1-methoxy-2-methyl-1-oxopropan-2-yl]carbamoyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2H-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylic acid Chemical compound C(#N)C1=CC=C(C=C1)C1=CC=C(C=C1)C[C@@](C)(C(=O)OC)NC(=O)C1N(CC=2C=C3C(=CC=2C1)OC[C@@H](O3)C1=CC=C(C=C1)OCC1=CC(=C(C=C1)Cl)Cl)C(=O)O CWMONKPMDOKAFE-IWZUKJADSA-N 0.000 description 1
- XYHIWUWOCXFFNO-NGCAANIMSA-N (3r,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C1=CC([C@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(O)=O)[C@@H](CC)C=2C=CC=CC=2)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 XYHIWUWOCXFFNO-NGCAANIMSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- YPIGTWWHUNHPGK-ANWICMFUSA-N (3s)-3-[4-[(3,4-dichlorobenzoyl)amino]phenyl]-7-[(2-methylpropan-2-yl)oxycarbonyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C1=CC([C@@H]2OC=3C=C4CN(C(CC4=CC=3OC2)C(O)=O)C(=O)OC(C)(C)C)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 YPIGTWWHUNHPGK-ANWICMFUSA-N 0.000 description 1
- ZDGBHAAILDAGTG-WSZLSEGOSA-N (3s,8s)-3-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C=1C([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(O)=O)[C@@H](CC)C=2C=CC=CC=2)=CC=CC=1OCC1=CC=C(Cl)C(Cl)=C1 ZDGBHAAILDAGTG-WSZLSEGOSA-N 0.000 description 1
- LJVRNPQQIFOFHY-ODTVBPJYSA-N (3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylbutyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound C1=CC([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(O)=O)[C@@H](CCC)C=2C=CC=CC=2)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 LJVRNPQQIFOFHY-ODTVBPJYSA-N 0.000 description 1
- ONTARJNWHFVCLJ-NZQKXSOJSA-N (3s,8s)-7-benzoyl-3-(4-hydroxyphenyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylic acid Chemical compound O([C@H](COC=1C=C2C[C@H]3C(=O)O)C=4C=CC(O)=CC=4)C=1C=C2CN3C(=O)C1=CC=CC=C1 ONTARJNWHFVCLJ-NZQKXSOJSA-N 0.000 description 1
- WKAXQZVOROMFLX-VHYZKNOSSA-N (3s,8s)-8-[[(1s)-1-carboxy-2-[4-(2,3-dimethylpyridin-4-yl)phenyl]ethyl]carbamoyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylic acid Chemical compound CC1=NC=CC(C=2C=CC(C[C@H](NC(=O)[C@H]3N(CC4=CC=5O[C@H](COC=5C=C4C3)C=3C=CC(OCC=4C=C(Cl)C(Cl)=CC=4)=CC=3)C(O)=O)C(O)=O)=CC=2)=C1C WKAXQZVOROMFLX-VHYZKNOSSA-N 0.000 description 1
- GXXSSUBJLJGYSD-UHFFFAOYSA-N (6-chlorosulfonyl-1,3-benzothiazol-2-yl)carbamic acid Chemical compound ClS(=O)(=O)C1=CC2=C(N=C(S2)NC(O)=O)C=C1 GXXSSUBJLJGYSD-UHFFFAOYSA-N 0.000 description 1
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 description 1
- 125000006586 (C3-C10) cycloalkylene group Chemical group 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- 125000001607 1,2,3-triazol-1-yl group Chemical group [*]N1N=NC([H])=C1[H] 0.000 description 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 description 1
- YZIFVWOCPGPNHB-UHFFFAOYSA-N 1,2-dichloro-4-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C(Cl)=C1 YZIFVWOCPGPNHB-UHFFFAOYSA-N 0.000 description 1
- 125000004317 1,3,5-triazin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=N1 0.000 description 1
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- VDFVNEFVBPFDSB-UHFFFAOYSA-N 1,3-dioxane Chemical compound C1COCOC1 VDFVNEFVBPFDSB-UHFFFAOYSA-N 0.000 description 1
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- LZIYAIRGDHSVED-UHFFFAOYSA-N 1-(bromomethyl)-3-chlorobenzene Chemical compound ClC1=CC=CC(CBr)=C1 LZIYAIRGDHSVED-UHFFFAOYSA-N 0.000 description 1
- FWLWTILKTABGKQ-UHFFFAOYSA-N 1-(bromomethyl)-3-methylbenzene Chemical compound CC1=CC=CC(CBr)=C1 FWLWTILKTABGKQ-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical group C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- FOZVXADQAHVUSV-UHFFFAOYSA-N 1-bromo-2-(2-bromoethoxy)ethane Chemical compound BrCCOCCBr FOZVXADQAHVUSV-UHFFFAOYSA-N 0.000 description 1
- ROKZAMCDHKVZIQ-UHFFFAOYSA-N 1-bromo-3,3-dimethylbutane Chemical compound CC(C)(C)CCBr ROKZAMCDHKVZIQ-UHFFFAOYSA-N 0.000 description 1
- XJSUFXFSUACKAT-UHFFFAOYSA-N 1-bromopropylbenzene Chemical compound CCC(Br)C1=CC=CC=C1 XJSUFXFSUACKAT-UHFFFAOYSA-N 0.000 description 1
- QUYJEYSRBCLJIZ-UHFFFAOYSA-N 1-methylpyrazole-3-carbaldehyde Chemical compound CN1C=CC(C=O)=N1 QUYJEYSRBCLJIZ-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- 125000004134 1-norbornyl group Chemical group [H]C1([H])C([H])([H])C2(*)C([H])([H])C([H])([H])C1([H])C2([H])[H] 0.000 description 1
- BSLCBYOXMDACSD-UHFFFAOYSA-N 1-oxido-6,7-dihydro-5h-cyclopenta[b]pyridin-1-ium Chemical compound [O-][N+]1=CC=CC2=C1CCC2 BSLCBYOXMDACSD-UHFFFAOYSA-N 0.000 description 1
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- KMGCKSAIIHOKCX-UHFFFAOYSA-N 2,3-dihydro-1h-inden-2-ol Chemical compound C1=CC=C2CC(O)CC2=C1 KMGCKSAIIHOKCX-UHFFFAOYSA-N 0.000 description 1
- CFMTVTYBZMKULI-UHFFFAOYSA-N 2,3-dimethyl-4-nitro-1-oxidopyridin-1-ium Chemical compound CC1=C(C)[N+]([O-])=CC=C1[N+]([O-])=O CFMTVTYBZMKULI-UHFFFAOYSA-N 0.000 description 1
- FUJSJWRORKKPAI-UHFFFAOYSA-N 2-(2,4-dichlorophenoxy)acetyl chloride Chemical compound ClC(=O)COC1=CC=C(Cl)C=C1Cl FUJSJWRORKKPAI-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- RQFROMMAQQTNIL-LLSVSLFMSA-N 2-[[(3s)-8-[[(1s)-1-carboxy-2-[4-(4-cyanophenyl)phenyl]ethyl]carbamoyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinolin-7-yl]methyl]benzoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)CC=1C(=CC=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 RQFROMMAQQTNIL-LLSVSLFMSA-N 0.000 description 1
- CYVWGLODALLLFP-UHFFFAOYSA-N 2-[tert-butyl(diphenyl)silyl]oxy-1-[4-[(3,4-dichlorophenyl)methoxy]phenyl]ethanol Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(C(C)(C)C)OCC(O)C(C=C1)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 CYVWGLODALLLFP-UHFFFAOYSA-N 0.000 description 1
- XUCWFAIPNYYXLN-UHFFFAOYSA-N 2-acetamido-5-methyl-1,3-thiazole-4-sulfonyl chloride Chemical compound CC(=O)NC1=NC(S(Cl)(=O)=O)=C(C)S1 XUCWFAIPNYYXLN-UHFFFAOYSA-N 0.000 description 1
- MBUPVGIGAMCMBT-UHFFFAOYSA-N 2-bromo-1-(4-nitrophenyl)ethanone Chemical compound [O-][N+](=O)C1=CC=C(C(=O)CBr)C=C1 MBUPVGIGAMCMBT-UHFFFAOYSA-N 0.000 description 1
- JTMYLQKKQFLIGV-UHFFFAOYSA-N 2-chloro-4-(chloromethyl)-1-methylbenzene Chemical compound CC1=CC=C(CCl)C=C1Cl JTMYLQKKQFLIGV-UHFFFAOYSA-N 0.000 description 1
- OKDGRDCXVWSXDC-UHFFFAOYSA-N 2-chloropyridine Chemical compound ClC1=CC=CC=N1 OKDGRDCXVWSXDC-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- BEDNMYGUVYQPTP-UHFFFAOYSA-N 2-methoxy-4-methylbenzenesulfonyl chloride Chemical compound COC1=CC(C)=CC=C1S(Cl)(=O)=O BEDNMYGUVYQPTP-UHFFFAOYSA-N 0.000 description 1
- GYOBZOBUOMDRRN-UHFFFAOYSA-N 2-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=CC=C1S(Cl)(=O)=O GYOBZOBUOMDRRN-UHFFFAOYSA-N 0.000 description 1
- AAOGHNLWLXOFQM-UHFFFAOYSA-N 2-methyl-6-(propan-2-ylamino)pyridine-3-sulfonyl chloride Chemical compound CC(C)NC1=CC=C(S(Cl)(=O)=O)C(C)=N1 AAOGHNLWLXOFQM-UHFFFAOYSA-N 0.000 description 1
- DGMOBVGABMBZSB-UHFFFAOYSA-N 2-methylpropanoyl chloride Chemical compound CC(C)C(Cl)=O DGMOBVGABMBZSB-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- WPHUUIODWRNJLO-UHFFFAOYSA-N 2-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=CC=C1S(Cl)(=O)=O WPHUUIODWRNJLO-UHFFFAOYSA-N 0.000 description 1
- WEQOIEZZHMJMEH-UHFFFAOYSA-N 2-o-tert-butyl 3-o-methyl 1h-isoquinoline-2,3-dicarboxylate Chemical compound C1=CC=C2CN(C(=O)OC(C)(C)C)C(C(=O)OC)=CC2=C1 WEQOIEZZHMJMEH-UHFFFAOYSA-N 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- VRGCYEIGVVTZCC-UHFFFAOYSA-N 3,4,5,6-tetrachlorocyclohexa-3,5-diene-1,2-dione Chemical compound ClC1=C(Cl)C(=O)C(=O)C(Cl)=C1Cl VRGCYEIGVVTZCC-UHFFFAOYSA-N 0.000 description 1
- VTXNOVCTHUBABW-UHFFFAOYSA-N 3,4-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C(Cl)=C1 VTXNOVCTHUBABW-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- MWWNNNAOGWPTQY-UHFFFAOYSA-N 3-nitrobenzenesulfonyl chloride Chemical compound [O-][N+](=O)C1=CC=CC(S(Cl)(=O)=O)=C1 MWWNNNAOGWPTQY-UHFFFAOYSA-N 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- ISFQLPGWXMGYKM-UHFFFAOYSA-N 4-(bromomethyl)-1,2-dimethylbenzene Chemical compound CC1=CC=C(CBr)C=C1C ISFQLPGWXMGYKM-UHFFFAOYSA-N 0.000 description 1
- UBQRAAXAHIKWRI-UHFFFAOYSA-N 4-(chloromethyl)-1,2-dimethylbenzene Chemical compound CC1=CC=C(CCl)C=C1C UBQRAAXAHIKWRI-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- CQMOYSYLLYARBD-UHFFFAOYSA-N 4-acetamido-2-methylbenzenesulfonyl chloride Chemical compound CC(=O)NC1=CC=C(S(Cl)(=O)=O)C(C)=C1 CQMOYSYLLYARBD-UHFFFAOYSA-N 0.000 description 1
- GRDXCFKBQWDAJH-UHFFFAOYSA-N 4-acetamidobenzenesulfonyl chloride Chemical compound CC(=O)NC1=CC=C(S(Cl)(=O)=O)C=C1 GRDXCFKBQWDAJH-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- LUDCJEGSWQBSKR-UHFFFAOYSA-N 4-bromo-2-propan-2-ylpyridine Chemical compound CC(C)C1=CC(Br)=CC=N1 LUDCJEGSWQBSKR-UHFFFAOYSA-N 0.000 description 1
- WYLAQZLXZDHAED-UHFFFAOYSA-N 4-bromo-2-propylpyridine Chemical compound CCCC1=CC(Br)=CC=N1 WYLAQZLXZDHAED-UHFFFAOYSA-N 0.000 description 1
- CPVMPCSZGBHELB-UHFFFAOYSA-N 4-bromo-6,7-dihydro-5h-cyclopenta[b]pyridine Chemical compound BrC1=CC=NC2=C1CCC2 CPVMPCSZGBHELB-UHFFFAOYSA-N 0.000 description 1
- BSDGZUDFPKIYQG-UHFFFAOYSA-N 4-bromopyridine Chemical compound BrC1=CC=NC=C1 BSDGZUDFPKIYQG-UHFFFAOYSA-N 0.000 description 1
- XOKDXPVXJWTSRM-UHFFFAOYSA-N 4-iodobenzonitrile Chemical compound IC1=CC=C(C#N)C=C1 XOKDXPVXJWTSRM-UHFFFAOYSA-N 0.000 description 1
- OGHAPVZVXLHURO-UHFFFAOYSA-N 4-methoxy-2-nitrobenzenesulfonyl chloride Chemical compound COC1=CC=C(S(Cl)(=O)=O)C([N+]([O-])=O)=C1 OGHAPVZVXLHURO-UHFFFAOYSA-N 0.000 description 1
- GRBBNZYMXKTQAI-UHFFFAOYSA-N 4-methyl-5-nitropyridin-2-amine Chemical compound CC1=CC(N)=NC=C1[N+]([O-])=O GRBBNZYMXKTQAI-UHFFFAOYSA-N 0.000 description 1
- FPJABYRHGJABIZ-UHFFFAOYSA-N 4-morpholin-4-ylbenzenesulfonyl chloride Chemical compound C1=CC(S(=O)(=O)Cl)=CC=C1N1CCOCC1 FPJABYRHGJABIZ-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- ABYPRALCFKJRCP-UHFFFAOYSA-N 6,7-dihydroxy-3,4-dihydro-1h-isoquinoline-2,3-dicarboxylic acid Chemical compound OC1=C(O)C=C2CN(C(O)=O)C(C(=O)O)CC2=C1 ABYPRALCFKJRCP-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- IMKNTDZQBJFGQR-UHFFFAOYSA-N 6-chloro-2-methylpyridine-3-sulfonyl chloride Chemical compound CC1=NC(Cl)=CC=C1S(Cl)(=O)=O IMKNTDZQBJFGQR-UHFFFAOYSA-N 0.000 description 1
- QXZKKHONVQGXAK-UHFFFAOYSA-N 6-chloropyridine-3-sulfonyl chloride Chemical compound ClC1=CC=C(S(Cl)(=O)=O)C=N1 QXZKKHONVQGXAK-UHFFFAOYSA-N 0.000 description 1
- IFOPVANOAWECQM-UHFFFAOYSA-N 6-methyl-5-nitro-n-propan-2-ylpyridin-2-amine Chemical compound CC(C)NC1=CC=C([N+]([O-])=O)C(C)=N1 IFOPVANOAWECQM-UHFFFAOYSA-N 0.000 description 1
- BGMZTBKXOFFTBJ-UHFFFAOYSA-N 6-methyl-5-nitropyridin-2-amine Chemical compound CC1=NC(N)=CC=C1[N+]([O-])=O BGMZTBKXOFFTBJ-UHFFFAOYSA-N 0.000 description 1
- AHISYUZBWDSPQL-UHFFFAOYSA-N 6-methylpyridine-2-carbaldehyde Chemical compound CC1=CC=CC(C=O)=N1 AHISYUZBWDSPQL-UHFFFAOYSA-N 0.000 description 1
- AJCDOAOTQFHTDM-LFHRXCRSSA-N 7-o-tert-butyl 8-o-methyl (3s)-3-[4-(cyclopentylmethoxy)phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C1=CC([C@H]2COC=3C=C4CC(N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=C1OCC1CCCC1 AJCDOAOTQFHTDM-LFHRXCRSSA-N 0.000 description 1
- GZAVSOIWGPMLFM-LFHRXCRSSA-N 7-o-tert-butyl 8-o-methyl (3s)-3-[4-[(3,4-dichlorobenzoyl)amino]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C1=CC([C@H]2COC=3C=C4CC(N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 GZAVSOIWGPMLFM-LFHRXCRSSA-N 0.000 description 1
- FZMGVDOPIYPEDC-DINWUYGQSA-N 7-o-tert-butyl 8-o-methyl (3s)-3-[4-[(3,4-dimethylphenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C1=CC([C@H]2COC=3C=C4CC(N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=C1OCC1=CC=C(C)C(C)=C1 FZMGVDOPIYPEDC-DINWUYGQSA-N 0.000 description 1
- LGDXECFNYBMBBV-VCUSLETLSA-N 7-o-tert-butyl 8-o-methyl (3s)-3-hydroxy-3-(4-nitrophenyl)-2,6,8,9-tetrahydro-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C1([C@@]2(O)COC=3C=C4CC(N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=C([N+]([O-])=O)C=C1 LGDXECFNYBMBBV-VCUSLETLSA-N 0.000 description 1
- RUUPOAWUUXZACM-NZQKXSOJSA-N 7-o-tert-butyl 8-o-methyl (3s,8s)-3-(4-acetyloxyphenyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C1([C@H]2COC=3C=C4C[C@H](N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=C(OC(C)=O)C=C1 RUUPOAWUUXZACM-NZQKXSOJSA-N 0.000 description 1
- RJFHZSNVGYCRAT-LBNVMWSVSA-N 7-o-tert-butyl 8-o-methyl (3s,8s)-3-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7,8-dicarboxylate Chemical compound C=1C([C@H]2COC=3C=C4C[C@H](N(CC4=CC=3O2)C(=O)OC(C)(C)C)C(=O)OC)=CC=CC=1OCC1=CC=C(Cl)C(Cl)=C1 RJFHZSNVGYCRAT-LBNVMWSVSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- XILDFUDDNSNLIF-YUTPAWSZSA-N C(#N)C1=CC=C(C=C1)C1=CC=C(C=C1)C[C@@H](C(=O)OC)NC(=O)C1N(CC=2C=C3C(=CC2C1)OC[C@@H](O3)C3=CC=C(C=C3)OCC3=CC(=C(C=C3)Cl)Cl)C(=O)O Chemical compound C(#N)C1=CC=C(C=C1)C1=CC=C(C=C1)C[C@@H](C(=O)OC)NC(=O)C1N(CC=2C=C3C(=CC2C1)OC[C@@H](O3)C3=CC=C(C=C3)OCC3=CC(=C(C=C3)Cl)Cl)C(=O)O XILDFUDDNSNLIF-YUTPAWSZSA-N 0.000 description 1
- OGXCHHJIBYABMB-AXUITJTPSA-N C(C)(=O)N1C[C@@H](OC2=CC=3CN(C(CC=3C=C12)C(N[C@@H](CC1=CC=C(C=C1)C1=CC=C(C=C1)C#N)C(=O)OC)=O)C(=O)O)C1=CC=C(C=C1)OCC1=CC(=C(C=C1)Cl)Cl Chemical compound C(C)(=O)N1C[C@@H](OC2=CC=3CN(C(CC=3C=C12)C(N[C@@H](CC1=CC=C(C=C1)C1=CC=C(C=C1)C#N)C(=O)OC)=O)C(=O)O)C1=CC=C(C=C1)OCC1=CC(=C(C=C1)Cl)Cl OGXCHHJIBYABMB-AXUITJTPSA-N 0.000 description 1
- CMFALDUTLXCINY-SKKDVOKBSA-N C(C)(=O)NC=1SC(=C(N=1)C)S(=O)(=O)N1CC=2C=C3C(=CC=2CC1C(=O)N[C@H](C(=O)O)CC1=CC=C(C=C1)C1=CC=C(C=C1)C#N)OC[C@@H](O3)C1=CC=C(C=C1)OCC Chemical compound C(C)(=O)NC=1SC(=C(N=1)C)S(=O)(=O)N1CC=2C=C3C(=CC=2CC1C(=O)N[C@H](C(=O)O)CC1=CC=C(C=C1)C1=CC=C(C=C1)C#N)OC[C@@H](O3)C1=CC=C(C=C1)OCC CMFALDUTLXCINY-SKKDVOKBSA-N 0.000 description 1
- HNNUWWCZUBBALB-XSBWBPONSA-N C(C)(=O)NC=1SC(=C(N=1)C)S(=O)(=O)N1CC=2C=C3C(=CC=2CC1C(=O)N[C@H](C(=O)O)CC1=CC=C(C=C1)C1=CC=C(C=C1)C#N)OC[C@@H](O3)C1=CC=C(C=C1)OCC1=CC=CC=C1 Chemical compound C(C)(=O)NC=1SC(=C(N=1)C)S(=O)(=O)N1CC=2C=C3C(=CC=2CC1C(=O)N[C@H](C(=O)O)CC1=CC=C(C=C1)C1=CC=C(C=C1)C#N)OC[C@@H](O3)C1=CC=C(C=C1)OCC1=CC=CC=C1 HNNUWWCZUBBALB-XSBWBPONSA-N 0.000 description 1
- NBECJDDGSXFXDW-WSZLSEGOSA-N C([C@@H](C(=O)OC)NC(=O)[C@H]1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OS(=O)(=O)C(F)(F)F)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OS(=O)(=O)C(F)(F)F)=CC=1)C(O)=O)C(C=C1)=CC=C1C1=CC=NC(C)=C1C NBECJDDGSXFXDW-WSZLSEGOSA-N 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 1
- AAGIIIUBFCDENA-INIZCTEOSA-N COC([C@H](CC1=C(C=CC=C1)C1=CC=C(C=C1)OC)N)=O Chemical compound COC([C@H](CC1=C(C=CC=C1)C1=CC=C(C=C1)OC)N)=O AAGIIIUBFCDENA-INIZCTEOSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 238000005750 Corey-Bakshi-Shibata reduction reaction Methods 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- HTQBXNHDCUEHJF-XWLPCZSASA-N Exenatide Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 241000282575 Gorilla Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- 241000764238 Isis Species 0.000 description 1
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 1
- NHTGHBARYWONDQ-JTQLQIEISA-N L-α-methyl-Tyrosine Chemical compound OC(=O)[C@](N)(C)CC1=CC=C(O)C=C1 NHTGHBARYWONDQ-JTQLQIEISA-N 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910020667 PBr3 Inorganic materials 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- 229910002666 PdCl2 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 229910006074 SO2NH2 Inorganic materials 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical compound C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- DYUAPKHFRXRMTL-UHFFFAOYSA-N [4-(trifluoromethyl)cyclohexyl]methanol Chemical compound OCC1CCC(C(F)(F)F)CC1 DYUAPKHFRXRMTL-UHFFFAOYSA-N 0.000 description 1
- XHRDEYPGTXPSIS-UHFFFAOYSA-N [5-(bromomethyl)-4-methyl-1,3-thiazol-2-yl]carbamic acid Chemical compound BrCC1=C(N=C(S1)NC(O)=O)C XHRDEYPGTXPSIS-UHFFFAOYSA-N 0.000 description 1
- MMUMGZYGAPGUKL-UHFFFAOYSA-N [5-(bromomethyl)pyridin-2-yl]carbamic acid Chemical compound OC(=O)NC1=CC=C(CBr)C=N1 MMUMGZYGAPGUKL-UHFFFAOYSA-N 0.000 description 1
- FLAJXCWBANPZSP-UHFFFAOYSA-N [5-(hydroxymethyl)pyridin-2-yl]carbamic acid Chemical compound OCC1=CC=C(NC(O)=O)N=C1 FLAJXCWBANPZSP-UHFFFAOYSA-N 0.000 description 1
- SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 150000003869 acetamides Chemical class 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 150000000475 acetylene derivatives Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000003302 alkenyloxy group Chemical group 0.000 description 1
- 125000005136 alkenylsulfinyl group Chemical group 0.000 description 1
- 125000005137 alkenylsulfonyl group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000005133 alkynyloxy group Chemical group 0.000 description 1
- 125000005134 alkynylsulfinyl group Chemical group 0.000 description 1
- 125000005139 alkynylsulfonyl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 150000003927 aminopyridines Chemical class 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 229950003476 aminothiazole Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000001499 aryl bromides Chemical class 0.000 description 1
- 150000001502 aryl halides Chemical class 0.000 description 1
- 150000001503 aryl iodides Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000004320 azepan-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 description 1
- 125000004273 azetidin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004567 azetidin-3-yl group Chemical group N1CC(C1)* 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- UHOVQNZJYSORNB-MZWXYZOWSA-N benzene-d6 Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004244 benzofuran-2-yl group Chemical group [H]C1=C(*)OC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 125000004532 benzofuran-3-yl group Chemical group O1C=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 1
- 125000004190 benzothiazol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N=C(*)SC2=C1[H] 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- JCZLABDVDPYLRZ-AWEZNQCLSA-N biphenylalanine Chemical class C1=CC(C[C@H](N)C(O)=O)=CC=C1C1=CC=CC=C1 JCZLABDVDPYLRZ-AWEZNQCLSA-N 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 229940084891 byetta Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- RBHJBMIOOPYDBQ-UHFFFAOYSA-N carbon dioxide;propan-2-one Chemical compound O=C=O.CC(C)=O RBHJBMIOOPYDBQ-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- KTHXBEHDVMTNOH-UHFFFAOYSA-N cyclobutanol Chemical compound OC1CCC1 KTHXBEHDVMTNOH-UHFFFAOYSA-N 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000004976 cyclobutylene group Chemical group 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000004977 cycloheptylene group Chemical group 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- VSSAZBXXNIABDN-UHFFFAOYSA-N cyclohexylmethanol Chemical compound OCC1CCCCC1 VSSAZBXXNIABDN-UHFFFAOYSA-N 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- WEPUZBYKXNKSDH-UHFFFAOYSA-N cyclopentanecarbonyl chloride Chemical compound ClC(=O)C1CCCC1 WEPUZBYKXNKSDH-UHFFFAOYSA-N 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- ISQVBYGGNVVVHB-UHFFFAOYSA-N cyclopentylmethanol Chemical compound OCC1CCCC1 ISQVBYGGNVVVHB-UHFFFAOYSA-N 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- IGSKHXTUVXSOMB-UHFFFAOYSA-N cyclopropylmethanamine Chemical compound NCC1CC1 IGSKHXTUVXSOMB-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 1
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Substances CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 125000000532 dioxanyl group Chemical group 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- QGBQGMHXBSLYLZ-UHFFFAOYSA-N ditert-butyl-(1-naphthalen-1-ylnaphthalen-2-yl)phosphane Chemical compound C1=CC=C2C(C3=C4C=CC=CC4=CC=C3P(C(C)(C)C)C(C)(C)C)=CC=CC2=C1 QGBQGMHXBSLYLZ-UHFFFAOYSA-N 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- WHQLQYRFIHPMNA-UHFFFAOYSA-N ethyl acetate;oxolane Chemical compound C1CCOC1.CCOC(C)=O WHQLQYRFIHPMNA-UHFFFAOYSA-N 0.000 description 1
- DXVYLFHTJZWTRF-UHFFFAOYSA-N ethyl iso-butyl ketone Natural products CCC(=O)CC(C)C DXVYLFHTJZWTRF-UHFFFAOYSA-N 0.000 description 1
- WUDNUHPRLBTKOJ-UHFFFAOYSA-N ethyl isocyanate Chemical compound CCN=C=O WUDNUHPRLBTKOJ-UHFFFAOYSA-N 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 125000001543 furan-2,5-diyl group Chemical group O1C(=CC=C1*)* 0.000 description 1
- 125000004281 furazan-3-yl group Chemical group [H]C1=NON=C1* 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 238000005417 image-selected in vivo spectroscopy Methods 0.000 description 1
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 1
- 125000004282 imidazolidin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])N([H])C1([H])* 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- MGXWVYUBJRZYPE-YUGYIWNOSA-N incretin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=C(O)C=C1 MGXWVYUBJRZYPE-YUGYIWNOSA-N 0.000 description 1
- 239000000859 incretin Substances 0.000 description 1
- 125000004129 indan-1-yl group Chemical group [H]C1=C([H])C([H])=C2C(=C1[H])C([H])([H])C([H])([H])C2([H])* 0.000 description 1
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 238000012739 integrated shape imaging system Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 125000004254 isoquinolin-1-yl group Chemical group [H]C1=C([H])C2=C([H])C([H])=C([H])C([H])=C2C(*)=N1 0.000 description 1
- 125000004551 isoquinolin-3-yl group Chemical group C1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 125000004552 isoquinolin-4-yl group Chemical group C1=NC=C(C2=CC=CC=C12)* 0.000 description 1
- VMNZQPRIUSJCOH-UHFFFAOYSA-N isoquinoline-8-carboxylic acid Chemical compound C1=NC=C2C(C(=O)O)=CC=CC2=C1 VMNZQPRIUSJCOH-UHFFFAOYSA-N 0.000 description 1
- 125000001793 isothiazol-3-yl group Chemical group [H]C1=C([H])C(*)=NS1 0.000 description 1
- 125000004500 isothiazol-4-yl group Chemical group S1N=CC(=C1)* 0.000 description 1
- 125000004501 isothiazol-5-yl group Chemical group S1N=CC=C1* 0.000 description 1
- 125000004284 isoxazol-3-yl group Chemical group [H]C1=C([H])C(*)=NO1 0.000 description 1
- 125000004498 isoxazol-4-yl group Chemical group O1N=CC(=C1)* 0.000 description 1
- 125000004499 isoxazol-5-yl group Chemical group O1N=CC=C1* 0.000 description 1
- 125000004285 isoxazolidin-3-yl group Chemical group [H]N1OC([H])([H])C([H])([H])C1([H])* 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000009988 metabolic benefit Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- AXGHPDQOHHPZPQ-SQKCAUCHSA-N methyl (2S)-2-amino-3-[4-(6,7-dihydro-5H-cyclopenta[b]pyridin-4-yl)phenyl]propanoate dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC2=C1CCC2 AXGHPDQOHHPZPQ-SQKCAUCHSA-N 0.000 description 1
- CPHKMDBOUKBUGH-LJQBVWCNSA-N methyl (2r)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate;hydrochloride Chemical compound Cl.C([C@H](C(=O)OC)NC(=O)C1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 CPHKMDBOUKBUGH-LJQBVWCNSA-N 0.000 description 1
- DHTOBCRRDQQFDF-CUOYHRFUSA-N methyl (2s)-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-(4-phenylphenyl)propanoate;hydrochloride Chemical compound Cl.C([C@@H](C(=O)OC)NC(=O)C1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=CC=C1 DHTOBCRRDQQFDF-CUOYHRFUSA-N 0.000 description 1
- IKJYXHJKOWUBIE-YLJLHNITSA-N methyl (2s)-2-[[(3s,8s)-3-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=C(OCC=2C=C(Cl)C(Cl)=CC=2)C=CC=1)C(C=C1)=CC=C1C1=CC=NC(C)=C1C IKJYXHJKOWUBIE-YLJLHNITSA-N 0.000 description 1
- ONIFDNPOWHWTKN-IIRRWZJPSA-N methyl (2s)-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)oxyphenyl]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1OC1=CC=NC(C)=C1C ONIFDNPOWHWTKN-IIRRWZJPSA-N 0.000 description 1
- QESUUXXYIDFJBN-VHYZKNOSSA-N methyl (2s)-2-[[(3s,8s)-7-benzoyl-3-(4-hydroxyphenyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(O)=CC=1)C(=O)C=1C=CC=CC=1)C(C=C1)=CC=C1C1=CC=NC(C)=C1C QESUUXXYIDFJBN-VHYZKNOSSA-N 0.000 description 1
- OOVDEPZODSXAMU-MERQFXBCSA-N methyl (2s)-2-amino-3-(4-hydroxyphenyl)-2-methylpropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@](C)(N)CC1=CC=C(O)C=C1 OOVDEPZODSXAMU-MERQFXBCSA-N 0.000 description 1
- ZABGKWGFGXZMDE-HNNXBMFYSA-N methyl (2s)-2-amino-3-(4-phenylphenyl)propanoate Chemical compound C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=CC=C1 ZABGKWGFGXZMDE-HNNXBMFYSA-N 0.000 description 1
- WCDKVWFWDPQMCU-GXKRWWSZSA-N methyl (2s)-2-amino-3-(4-pyridazin-4-ylphenyl)propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NN=C1 WCDKVWFWDPQMCU-GXKRWWSZSA-N 0.000 description 1
- JVESDFDDVMRUSG-UTLKBRERSA-N methyl (2s)-2-amino-3-(4-pyridin-3-yloxyphenyl)propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1OC1=CC=CN=C1 JVESDFDDVMRUSG-UTLKBRERSA-N 0.000 description 1
- YNTJMRFPJOFPBB-UTLKBRERSA-N methyl (2s)-2-amino-3-(4-pyridin-3-ylphenyl)propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=CN=C1 YNTJMRFPJOFPBB-UTLKBRERSA-N 0.000 description 1
- GLGPKPQQVWBNHT-UTLKBRERSA-N methyl (2s)-2-amino-3-(4-pyridin-4-yloxyphenyl)propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1OC1=CC=NC=C1 GLGPKPQQVWBNHT-UTLKBRERSA-N 0.000 description 1
- KUYHWWRTSRRQBZ-AWEZNQCLSA-N methyl (2s)-2-amino-3-(4-pyridin-4-ylphenyl)propanoate Chemical compound C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC=C1 KUYHWWRTSRRQBZ-AWEZNQCLSA-N 0.000 description 1
- QZJVXDVJAKAXBA-UQKRIMTDSA-N methyl (2s)-2-amino-3-(4-pyridin-4-ylphenyl)propanoate;hydrochloride Chemical compound Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC=C1 QZJVXDVJAKAXBA-UQKRIMTDSA-N 0.000 description 1
- PIUNBHWGWRIUQG-LTCKWSDVSA-N methyl (2s)-2-amino-3-(4-pyrimidin-4-ylphenyl)propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC=N1 PIUNBHWGWRIUQG-LTCKWSDVSA-N 0.000 description 1
- LDJINKGMHULDDJ-RMRYJAPISA-N methyl (2s)-2-amino-3-(4-quinolin-4-ylphenyl)propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC2=CC=CC=C12 LDJINKGMHULDDJ-RMRYJAPISA-N 0.000 description 1
- QKUJYEXCHKMXCJ-NXCGSPNESA-N methyl (2s)-2-amino-3-[(2s)-2-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]propanoate;hydrochloride Chemical compound Cl.C=1C([C@@H]2OC3=CC=C(C=C3OC2)C[C@H](N)C(=O)OC)=CC=CC=1OCC1=CC=C(Cl)C(Cl)=C1 QKUJYEXCHKMXCJ-NXCGSPNESA-N 0.000 description 1
- QQPJRKNRJFFDGM-XUZZJYLKSA-N methyl (2s)-2-amino-3-[(2s)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]propanoate Chemical compound C1=CC([C@@H]2OC3=CC=C(C=C3OC2)C[C@H](N)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 QQPJRKNRJFFDGM-XUZZJYLKSA-N 0.000 description 1
- AEYXEFACMZSBHG-CHXZROHQSA-N methyl (2s)-2-amino-3-[2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]propanoate;hydrochloride Chemical compound Cl.C1OC2=CC(C[C@H](N)C(=O)OC)=CC=C2OC1C(C=C1)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 AEYXEFACMZSBHG-CHXZROHQSA-N 0.000 description 1
- WZQQREOQRMDGBG-GXKRWWSZSA-N methyl (2s)-2-amino-3-[4-(1-methylpyrazol-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CN(C)N=C1 WZQQREOQRMDGBG-GXKRWWSZSA-N 0.000 description 1
- BOFVVYUFGLYKPK-ZOWNYOTGSA-N methyl (2s)-2-amino-3-[4-(2,5-dimethylpyrazol-3-yl)phenyl]propanoate;hydrochloride Chemical compound Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC(C)=NN1C BOFVVYUFGLYKPK-ZOWNYOTGSA-N 0.000 description 1
- KZJUKZLKCIDTJH-SQKCAUCHSA-N methyl (2s)-2-amino-3-[4-(2,5-dimethylpyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC(C)=NC=C1C KZJUKZLKCIDTJH-SQKCAUCHSA-N 0.000 description 1
- ADUBVOOKGZJCOK-LTCKWSDVSA-N methyl (2s)-2-amino-3-[4-(2,6-difluoropyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC(F)=NC(F)=C1 ADUBVOOKGZJCOK-LTCKWSDVSA-N 0.000 description 1
- WFIWHWIZKZQLQS-SQKCAUCHSA-N methyl (2s)-2-amino-3-[4-(2,6-dimethylpyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC(C)=NC(C)=C1 WFIWHWIZKZQLQS-SQKCAUCHSA-N 0.000 description 1
- ZOXHCJRTMIFOOK-GXKRWWSZSA-N methyl (2s)-2-amino-3-[4-(2-aminopyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC(N)=C1 ZOXHCJRTMIFOOK-GXKRWWSZSA-N 0.000 description 1
- MMRUERBYEIBSEU-LTCKWSDVSA-N methyl (2s)-2-amino-3-[4-(2-aminopyrimidin-5-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CN=C(N)N=C1 MMRUERBYEIBSEU-LTCKWSDVSA-N 0.000 description 1
- FXKGJSZSGGMWLG-SQKCAUCHSA-N methyl (2s)-2-amino-3-[4-(2-ethylpyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=NC(CC)=CC(C=2C=CC(C[C@H](N)C(=O)OC)=CC=2)=C1 FXKGJSZSGGMWLG-SQKCAUCHSA-N 0.000 description 1
- HTKCBDIOOBGMHO-GXKRWWSZSA-N methyl (2s)-2-amino-3-[4-(2-fluoropyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC(F)=C1 HTKCBDIOOBGMHO-GXKRWWSZSA-N 0.000 description 1
- VEEWDEKPXLEUIK-UTLKBRERSA-N methyl (2s)-2-amino-3-[4-(2-methoxypyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC(OC)=C1 VEEWDEKPXLEUIK-UTLKBRERSA-N 0.000 description 1
- HBIVMGDVKRRTDK-LTCKWSDVSA-N methyl (2s)-2-amino-3-[4-(2-methylpyrazol-3-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NN1C HBIVMGDVKRRTDK-LTCKWSDVSA-N 0.000 description 1
- QLEXCAHRRZTNCN-CKUXDGONSA-N methyl (2s)-2-amino-3-[4-(2-methylpyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC(C)=C1 QLEXCAHRRZTNCN-CKUXDGONSA-N 0.000 description 1
- KDBKOPUMAFHOPX-SQKCAUCHSA-N methyl (2s)-2-amino-3-[4-(2-propan-2-ylpyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC(C(C)C)=C1 KDBKOPUMAFHOPX-SQKCAUCHSA-N 0.000 description 1
- SCYCMIXUYFJDKF-RMRYJAPISA-N methyl (2s)-2-amino-3-[4-(2-propylpyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=NC(CCC)=CC(C=2C=CC(C[C@H](N)C(=O)OC)=CC=2)=C1 SCYCMIXUYFJDKF-RMRYJAPISA-N 0.000 description 1
- YHERHCNWQURTLQ-UTLKBRERSA-N methyl (2s)-2-amino-3-[4-(3-fluoropyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC=C1F YHERHCNWQURTLQ-UTLKBRERSA-N 0.000 description 1
- GSOMWHZFPZNEMX-UTLKBRERSA-N methyl (2s)-2-amino-3-[4-(3-methoxypyridin-4-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC=C1OC GSOMWHZFPZNEMX-UTLKBRERSA-N 0.000 description 1
- JTPMAMGFSDCWSW-SQKCAUCHSA-N methyl (2s)-2-amino-3-[4-(3-methylphenyl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=CC(C)=C1 JTPMAMGFSDCWSW-SQKCAUCHSA-N 0.000 description 1
- QGCPUNGQJSRSQM-NTISSMGPSA-N methyl (2s)-2-amino-3-[4-(4-cyano-3-fluorophenyl)phenyl]propanoate;hydrochloride Chemical compound Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(C#N)C(F)=C1 QGCPUNGQJSRSQM-NTISSMGPSA-N 0.000 description 1
- NMCROLOVMHXPSL-HNNXBMFYSA-N methyl (2s)-2-amino-3-[4-(4-fluorophenyl)phenyl]propanoate Chemical compound C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(F)C=C1 NMCROLOVMHXPSL-HNNXBMFYSA-N 0.000 description 1
- HNAUTRSQBWZHGJ-NTISSMGPSA-N methyl (2s)-2-amino-3-[4-(4-methoxyphenyl)phenyl]propanoate;hydrochloride Chemical compound Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(OC)C=C1 HNAUTRSQBWZHGJ-NTISSMGPSA-N 0.000 description 1
- BOZVHPFMZPKTRE-INIZCTEOSA-N methyl (2s)-2-amino-3-[4-(4-methylphenyl)phenyl]propanoate Chemical compound C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(C)C=C1 BOZVHPFMZPKTRE-INIZCTEOSA-N 0.000 description 1
- NCIPTOKUHQWFBY-NTISSMGPSA-N methyl (2s)-2-amino-3-[4-(4-methylphenyl)phenyl]propanoate;hydrochloride Chemical compound Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(C)C=C1 NCIPTOKUHQWFBY-NTISSMGPSA-N 0.000 description 1
- FWBUCIPBENKDCL-GXKRWWSZSA-N methyl (2s)-2-amino-3-[4-(6-aminopyridin-3-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(N)N=C1 FWBUCIPBENKDCL-GXKRWWSZSA-N 0.000 description 1
- SNRYGKFTMWDHME-CKUXDGONSA-N methyl (2s)-2-amino-3-[4-(6-cyanopyridin-3-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(C#N)N=C1 SNRYGKFTMWDHME-CKUXDGONSA-N 0.000 description 1
- UZQNTNOCMBHTHJ-CKUXDGONSA-N methyl (2s)-2-amino-3-[4-(6-methylpyridin-3-yl)phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(C)N=C1 UZQNTNOCMBHTHJ-CKUXDGONSA-N 0.000 description 1
- MLILKESKEVNHKE-CKUXDGONSA-N methyl (2s)-2-amino-3-[4-[2-(hydroxymethyl)pyridin-4-yl]phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC(CO)=C1 MLILKESKEVNHKE-CKUXDGONSA-N 0.000 description 1
- WNBCFEWMVAWWRM-GXKRWWSZSA-N methyl (2s)-2-amino-3-[4-[2-(trifluoromethyl)pyridin-4-yl]phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=NC(C(F)(F)F)=C1 WNBCFEWMVAWWRM-GXKRWWSZSA-N 0.000 description 1
- HRJQWRTUPVHRBT-RSAXXLAASA-N methyl (2s)-2-amino-3-[4-[4-(trifluoromethyl)phenyl]phenyl]propanoate;hydrochloride Chemical compound Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(C(F)(F)F)C=C1 HRJQWRTUPVHRBT-RSAXXLAASA-N 0.000 description 1
- GJKXBQRPEONFLG-CKUXDGONSA-N methyl (2s)-2-amino-3-[4-[6-(dimethylamino)pyridin-3-yl]phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(N(C)C)N=C1 GJKXBQRPEONFLG-CKUXDGONSA-N 0.000 description 1
- HTGCHTIDQKPGIA-CKUXDGONSA-N methyl (2s)-2-amino-3-[4-[6-(hydroxymethyl)pyridin-3-yl]phenyl]propanoate;dihydrochloride Chemical compound Cl.Cl.C1=CC(C[C@H](N)C(=O)OC)=CC=C1C1=CC=C(CO)N=C1 HTGCHTIDQKPGIA-CKUXDGONSA-N 0.000 description 1
- OLODBSAKHNXKPY-NSHDSACASA-N methyl (2s)-3-(3-bromo-4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound CC(C)(C)OC(=O)N[C@H](C(=O)OC)CC1=CC=C(O)C(Br)=C1 OLODBSAKHNXKPY-NSHDSACASA-N 0.000 description 1
- ZOSBOGJFIOVFCW-ODTVBPJYSA-N methyl (2s)-3-[(2s)-2-(4-acetyloxyphenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(4-nitrophenyl)sulfonyl-[(1s)-1-phenylpropyl]amino]propanoate Chemical compound C1([C@@H]2OC3=CC=C(C=C3OC2)C[C@H](N([C@@H](CC)C=2C=CC=CC=2)S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)C(=O)OC)=CC=C(OC(C)=O)C=C1 ZOSBOGJFIOVFCW-ODTVBPJYSA-N 0.000 description 1
- YLBJCHJGSFAUQU-QFBILLFUSA-N methyl (2s)-3-[(2s)-2-(4-acetyloxyphenyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2-aminopropanoate Chemical compound C1([C@@H]2OC3=CC=C(C=C3OC2)C[C@H](N)C(=O)OC)=CC=C(OC(C)=O)C=C1 YLBJCHJGSFAUQU-QFBILLFUSA-N 0.000 description 1
- XVWMHDVHFPHVOB-RPLLCQBOSA-N methyl (2s)-3-[(2s)-2-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound C=1C([C@@H]2OC3=CC=C(C=C3OC2)C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=CC=1OCC1=CC=C(Cl)C(Cl)=C1 XVWMHDVHFPHVOB-RPLLCQBOSA-N 0.000 description 1
- WGXVUDWIBURIEX-VHYZKNOSSA-N methyl (2s)-3-[(2s)-2-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(4-nitrophenyl)sulfonyl-[(1s)-1-phenylpropyl]amino]propanoate Chemical compound C=1C([C@@H]2OC3=CC=C(C=C3OC2)C[C@H](N([C@@H](CC)C=2C=CC=CC=2)S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)C(=O)OC)=CC=CC=1OCC1=CC=C(Cl)C(Cl)=C1 WGXVUDWIBURIEX-VHYZKNOSSA-N 0.000 description 1
- PPAPOWBYYFKEST-WSZLSEGOSA-N methyl (2s)-3-[(2s)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[[(1s)-1-phenylpropyl]amino]propanoate Chemical compound C1=CC([C@@H]2OC3=CC=C(C=C3OC2)C[C@H](N[C@@H](CC)C=2C=CC=CC=2)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 PPAPOWBYYFKEST-WSZLSEGOSA-N 0.000 description 1
- HEDULFULVLLAHM-BXXZMZEQSA-N methyl (2s)-3-[2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-(propan-2-ylamino)propanoate Chemical compound C1OC2=CC(C[C@@H](C(=O)OC)NC(C)C)=CC=C2OC1C(C=C1)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 HEDULFULVLLAHM-BXXZMZEQSA-N 0.000 description 1
- WVANWKCNVUQWKC-CUOYHRFUSA-N methyl (2s)-3-[4-(4-chlorophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate;hydrochloride Chemical compound Cl.C([C@@H](C(=O)OC)NC(=O)C1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(Cl)C=C1 WVANWKCNVUQWKC-CUOYHRFUSA-N 0.000 description 1
- HSASQFQFOHAJFQ-XBEPADRLSA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-(4-ethoxyphenyl)-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate;hydrochloride Chemical compound Cl.C1=CC(OCC)=CC=C1[C@@H]1OC2=CC(CNC(C3)C(=O)N[C@@H](CC=4C=CC(=CC=4)C=4C=CC(=CC=4)C#N)C(=O)OC)=C3C=C2OC1 HSASQFQFOHAJFQ-XBEPADRLSA-N 0.000 description 1
- KQGKFGPLFWMQGN-CUOYHRFUSA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorobenzoyl)amino]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate;hydrochloride Chemical compound Cl.C([C@@H](C(=O)OC)NC(=O)C1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(NC(=O)C=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 KQGKFGPLFWMQGN-CUOYHRFUSA-N 0.000 description 1
- YQCZOZPZVSCMDE-NVJPACMSSA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-2-methylpropanoate;hydrochloride Chemical compound Cl.C([C@@](C)(C(=O)OC)NC(=O)C1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 YQCZOZPZVSCMDE-NVJPACMSSA-N 0.000 description 1
- XELNJDJVFFLKMR-LLSVSLFMSA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-(pyridin-2-ylmethyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)CC=1N=CC=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 XELNJDJVFFLKMR-LLSVSLFMSA-N 0.000 description 1
- CPHKMDBOUKBUGH-ROYBKCIRSA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-[[(3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]propanoate;hydrochloride Chemical compound Cl.C([C@@H](C(=O)OC)NC(=O)[C@H]1NCC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 CPHKMDBOUKBUGH-ROYBKCIRSA-N 0.000 description 1
- SFBFOJAPSYMOEM-SANMLTNESA-N methyl (2s)-3-[4-(4-cyanophenyl)phenyl]-2-methyl-2-(phenylmethoxycarbonylamino)propanoate Chemical compound C([C@@](C)(C(=O)OC)NC(=O)OCC=1C=CC=CC=1)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 SFBFOJAPSYMOEM-SANMLTNESA-N 0.000 description 1
- FXRUEMUFUNIGQC-SFHVURJKSA-N methyl (2s)-3-[4-[2-(hydroxymethyl)pyridin-4-yl]phenyl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound C1=CC(C[C@@H](C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1C1=CC=NC(CO)=C1 FXRUEMUFUNIGQC-SFHVURJKSA-N 0.000 description 1
- DYKLPYKFQICXER-JHFJJOSTSA-N methyl (3r,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylate Chemical compound C1=CC([C@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(=O)OC)[C@@H](CC)C=2C=CC=CC=2)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 DYKLPYKFQICXER-JHFJJOSTSA-N 0.000 description 1
- FZOKCBXIRHOWQE-MPSNESSQSA-N methyl (3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-propan-2-yl-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylate Chemical compound C1=CC([C@H]2COC=3C=C4CC(N(CC4=CC=3O2)C(C)C)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 FZOKCBXIRHOWQE-MPSNESSQSA-N 0.000 description 1
- LPDXYVVKLAIOTG-QRPNPIFTSA-N methyl (3s)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylate;hydrochloride Chemical compound Cl.OC1=C(O)C=C2CN[C@H](C(=O)OC)CC2=C1 LPDXYVVKLAIOTG-QRPNPIFTSA-N 0.000 description 1
- AWICHGXVMPHEBI-QXTIUPHPSA-N methyl (3s,8s)-3-(4-acetyloxyphenyl)-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylate Chemical compound C1([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(=O)OC)[C@@H](CC)C=2C=CC=CC=2)=CC=C(OC(C)=O)C=C1 AWICHGXVMPHEBI-QXTIUPHPSA-N 0.000 description 1
- JZBIYTPQIYMPQM-JYFHCDHNSA-N methyl (3s,8s)-3-(4-acetyloxyphenyl)-7-benzoyl-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylate Chemical compound O([C@H](COC=1C=C2C[C@H]3C(=O)OC)C=4C=CC(OC(C)=O)=CC=4)C=1C=C2CN3C(=O)C1=CC=CC=C1 JZBIYTPQIYMPQM-JYFHCDHNSA-N 0.000 description 1
- YFMVNOXRBLBCRF-ODTVBPJYSA-N methyl (3s,8s)-3-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylate Chemical compound C=1C([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(=O)OC)[C@@H](CC)C=2C=CC=CC=2)=CC=CC=1OCC1=CC=C(Cl)C(Cl)=C1 YFMVNOXRBLBCRF-ODTVBPJYSA-N 0.000 description 1
- DYKLPYKFQICXER-JSWXEYCZSA-N methyl (3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1r)-1-phenylpropyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylate Chemical compound C1=CC([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(=O)OC)[C@H](CC)C=2C=CC=CC=2)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 DYKLPYKFQICXER-JSWXEYCZSA-N 0.000 description 1
- BXJHUPQAIDRVEN-IGVZRYHESA-N methyl (3s,8s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-7-[(1s)-1-phenylbutyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-8-carboxylate Chemical compound C1=CC([C@@H]2OC=3C=C4CN([C@@H](CC4=CC=3OC2)C(=O)OC)[C@@H](CCC)C=2C=CC=CC=2)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 BXJHUPQAIDRVEN-IGVZRYHESA-N 0.000 description 1
- LTCNMAXNNIYTLU-UHFFFAOYSA-N methyl 2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2-hydroxyacetate Chemical compound C1=CC(C(O)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 LTCNMAXNNIYTLU-UHFFFAOYSA-N 0.000 description 1
- KSKRPHSHPQTWJK-HHHXNRCGSA-N methyl 3-[(2S)-2-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-2,3-dihydro-1,4-benzodioxin-6-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]prop-2-enoate Chemical compound C1=CC([C@@H]2OC3=CC=C(C=C3OC2)C=C(NC(=O)OC(C)(C)C)C(=O)OC)=CC=C1OCC1=CC=C(Cl)C(Cl)=C1 KSKRPHSHPQTWJK-HHHXNRCGSA-N 0.000 description 1
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 description 1
- 125000004572 morpholin-3-yl group Chemical group N1C(COCC1)* 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- RXLYNDDWAMZCDD-UHFFFAOYSA-N n-(4-methyl-5-nitropyridin-2-yl)acetamide Chemical compound CC(=O)NC1=CC(C)=C([N+]([O-])=O)C=N1 RXLYNDDWAMZCDD-UHFFFAOYSA-N 0.000 description 1
- QIYVKUNPXMATML-UHFFFAOYSA-N n-(5-amino-6-methylpyridin-2-yl)-n-(cyclobutylmethyl)acetamide Chemical compound C=1C=C(N)C(C)=NC=1N(C(=O)C)CC1CCC1 QIYVKUNPXMATML-UHFFFAOYSA-N 0.000 description 1
- APOWIBWCHFFTST-UHFFFAOYSA-N n-(6-methyl-5-nitropyridin-2-yl)acetamide Chemical compound CC(=O)NC1=CC=C([N+]([O-])=O)C(C)=N1 APOWIBWCHFFTST-UHFFFAOYSA-N 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- BTFQKIATRPGRBS-UHFFFAOYSA-N o-tolualdehyde Chemical compound CC1=CC=CC=C1C=O BTFQKIATRPGRBS-UHFFFAOYSA-N 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 125000004287 oxazol-2-yl group Chemical group [H]C1=C([H])N=C(*)O1 0.000 description 1
- 125000003145 oxazol-4-yl group Chemical group O1C=NC(=C1)* 0.000 description 1
- 125000004304 oxazol-5-yl group Chemical group O1C=NC=C1* 0.000 description 1
- LVSJDHGRKAEGLX-UHFFFAOYSA-N oxolane;2,2,2-trifluoroacetic acid Chemical compound C1CCOC1.OC(=O)C(F)(F)F LVSJDHGRKAEGLX-UHFFFAOYSA-N 0.000 description 1
- 150000002940 palladium Chemical class 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000035778 pathophysiological process Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 125000006551 perfluoro alkylene group Chemical group 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000002856 peripheral neuron Anatomy 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 1
- IPNPIHIZVLFAFP-UHFFFAOYSA-N phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004574 piperidin-2-yl group Chemical group N1C(CCCC1)* 0.000 description 1
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 1
- IIKFXOLJMNWWCH-UHFFFAOYSA-N piperidine-1,4-dicarboxylic acid Chemical compound OC(=O)C1CCN(C(O)=O)CC1 IIKFXOLJMNWWCH-UHFFFAOYSA-N 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 1
- GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 1
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 description 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 125000004159 quinolin-2-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C([H])C(*)=NC2=C1[H] 0.000 description 1
- 125000004548 quinolin-3-yl group Chemical group N1=CC(=CC2=CC=CC=C12)* 0.000 description 1
- 125000004549 quinolin-4-yl group Chemical group N1=CC=C(C2=CC=CC=C12)* 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical class N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- VEMKTZHHVJILDY-UHFFFAOYSA-N resmethrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UHFFFAOYSA-N 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000003979 response to food Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- YEUSLPIIQGZHQB-UHFFFAOYSA-N s,s'-(1,3-phenylene-bis(1,2-ethanediyl))bis-isothiourea Chemical compound NC(=N)SCCC1=CC=CC(CCSC(N)=N)=C1 YEUSLPIIQGZHQB-UHFFFAOYSA-N 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical compound [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- XRQDIZPSPMXCKL-DHUDCZEASA-N tert-butyl (3s)-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-8-[[(2s)-3-[4-(4-fluorophenyl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1C1=CC=C(F)C=C1 XRQDIZPSPMXCKL-DHUDCZEASA-N 0.000 description 1
- HUKROHLIRDDKTD-HWUAAHNXSA-N tert-butyl (3s)-8-[[(2r)-3-[4-(4-cyanophenyl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@H](C(=O)OC)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 HUKROHLIRDDKTD-HWUAAHNXSA-N 0.000 description 1
- HGAHIDLGUWYIRP-DHUDCZEASA-N tert-butyl (3s)-8-[[(2s)-3-[4-(4-chlorophenyl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1C1=CC=C(Cl)C=C1 HGAHIDLGUWYIRP-DHUDCZEASA-N 0.000 description 1
- HUKROHLIRDDKTD-XSBWBPONSA-N tert-butyl (3s)-8-[[(2s)-3-[4-(4-cyanophenyl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1 HUKROHLIRDDKTD-XSBWBPONSA-N 0.000 description 1
- WZGLJROWLPHGNZ-PTHAWZAQSA-N tert-butyl (3s)-8-[[(2s)-5-(4-cyanophenyl)-1-methoxy-1-oxopent-4-yn-2-yl]carbamoyl]-3-[4-[(3,4-dichlorophenyl)methoxy]phenyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)C1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=CC(OCC=2C=C(Cl)C(Cl)=CC=2)=CC=1)C(=O)OC(C)(C)C)C#CC1=CC=C(C#N)C=C1 WZGLJROWLPHGNZ-PTHAWZAQSA-N 0.000 description 1
- NAJRDKZEBVDHFC-TYQMUXPXSA-N tert-butyl (3s,8s)-3-[3-[(3,4-dichlorophenyl)methoxy]phenyl]-8-[[(2s)-3-[4-(2,3-dimethylpyridin-4-yl)oxyphenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=C(OCC=2C=C(Cl)C(Cl)=CC=2)C=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1OC1=CC=NC(C)=C1C NAJRDKZEBVDHFC-TYQMUXPXSA-N 0.000 description 1
- RWKJKIBOUWGCIU-VLSLJKOQSA-N tert-butyl (3s,8s)-8-[[(2s)-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]-1-methoxy-1-oxopropan-2-yl]carbamoyl]-3-(3-hydroxyphenyl)-3,6,8,9-tetrahydro-2h-[1,4]dioxino[2,3-g]isoquinoline-7-carboxylate Chemical compound C([C@@H](C(=O)OC)NC(=O)[C@H]1N(CC2=CC=3O[C@H](COC=3C=C2C1)C=1C=C(O)C=CC=1)C(=O)OC(C)(C)C)C(C=C1)=CC=C1C1=CC=NC(C)=C1C RWKJKIBOUWGCIU-VLSLJKOQSA-N 0.000 description 1
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004187 tetrahydropyran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- RAOIDOHSFRTOEL-UHFFFAOYSA-N tetrahydrothiophene Chemical compound C1CCSC1 RAOIDOHSFRTOEL-UHFFFAOYSA-N 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 description 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 description 1
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 description 1
- 125000004300 thiazolidin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])SC1([H])* 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 125000004569 thiomorpholin-2-yl group Chemical group N1CC(SCC1)* 0.000 description 1
- 125000004570 thiomorpholin-3-yl group Chemical group N1C(CSCC1)* 0.000 description 1
- 125000004571 thiomorpholin-4-yl group Chemical group N1(CCSCC1)* 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 1
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/06—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Secondary Cells (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16452309P | 2009-03-30 | 2009-03-30 | |
| US30934810P | 2010-03-01 | 2010-03-01 | |
| PCT/US2010/029172 WO2010114824A1 (en) | 2009-03-30 | 2010-03-30 | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2413693T3 true DK2413693T3 (en) | 2015-11-16 |
Family
ID=42828657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10779665.8T DK2413693T3 (en) | 2009-03-30 | 2010-03-30 | Substituted azoanthracenderivater, pharmaceutical compositions and methods for use thereof |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US8383644B2 (enExample) |
| EP (1) | EP2413693B1 (enExample) |
| JP (1) | JP5755217B2 (enExample) |
| KR (1) | KR101732978B1 (enExample) |
| CN (1) | CN102378574B (enExample) |
| AU (1) | AU2010232750B2 (enExample) |
| BR (1) | BRPI1013579A2 (enExample) |
| CA (1) | CA2757084C (enExample) |
| DK (1) | DK2413693T3 (enExample) |
| EA (1) | EA023430B1 (enExample) |
| ES (1) | ES2553645T3 (enExample) |
| IL (1) | IL214822A (enExample) |
| MA (1) | MA33219B1 (enExample) |
| MX (1) | MX2011010347A (enExample) |
| SG (1) | SG174205A1 (enExample) |
| TN (1) | TN2011000437A1 (enExample) |
| WO (1) | WO2010114824A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102378574B (zh) | 2009-03-30 | 2013-11-20 | 转化技术制药公司 | 取代的偶氮蒽衍生物、药物组合物及其使用方法 |
| CN103030646B (zh) * | 2011-09-29 | 2016-08-24 | 上海恒瑞医药有限公司 | 苯并二氧六环类衍生物、其制备方法及其在医药上的应用 |
| US8822527B2 (en) | 2011-10-17 | 2014-09-02 | Biotheryx, Inc. | Substituted biaryl alkyl amides |
| KR102165434B1 (ko) * | 2013-01-17 | 2020-10-14 | 브이티브이 테라퓨틱스 엘엘씨 | 2형 당뇨병 및 다른 장애의 치료를 위한 glp1r 작용제 및 메트포민의 조합 및 이것들의 사용법 |
| CN107072970B (zh) | 2014-08-29 | 2021-05-25 | 得克萨斯州大学系统董事会 | 用于治疗癌症和其他增殖性疾病的新的辣椒平类似物 |
| JOP20190060A1 (ar) | 2016-09-26 | 2019-03-26 | Chugai Pharmaceutical Co Ltd | مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1 |
| TW201925204A (zh) * | 2017-11-22 | 2019-07-01 | 日商第一三共股份有限公司 | 稠合三環化合物 |
| JP7461104B2 (ja) * | 2017-11-29 | 2024-04-03 | 中外製薬株式会社 | Glp-1受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物 |
| CA3090823A1 (en) * | 2018-05-08 | 2019-11-14 | Vtv Therapeutics Llc | Therapeutic uses of glp1r agonists |
| US10934279B2 (en) | 2018-06-13 | 2021-03-02 | Pfizer Inc. | GLP-1 receptor agonists and uses thereof |
| CA3140972C (en) | 2019-05-20 | 2024-06-18 | Pfizer Inc. | Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases |
| MX2022008938A (es) * | 2020-01-20 | 2022-10-18 | Crescenta Biosciences | Nuevos compuestos moduladores del metabolismo celular y usos de los mismos. |
| WO2021196951A1 (zh) | 2020-04-01 | 2021-10-07 | 杭州中美华东制药有限公司 | Glp-1受体激动剂游离碱的药学上可接受的酸式盐及其制备方法 |
| CN115461344B (zh) * | 2020-04-01 | 2024-01-12 | 杭州中美华东制药有限公司 | 一种glp-1受体激动剂的晶型a及其制备方法 |
| TW202144340A (zh) | 2020-04-03 | 2021-12-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 稠合咪唑類衍生物、其製備方法及其在醫藥上的應用 |
| TW202210461A (zh) | 2020-05-28 | 2022-03-16 | 中國大陸商杭州中美華東製藥有限公司 | 一種(s)—2—胺基—3—(4—(2,3—二甲基吡啶—4—基)苯基)丙酸甲酯二酸鹽的製備方法 |
| TW202206420A (zh) | 2020-05-28 | 2022-02-16 | 美商維特衛治療有限責任公司 | 用於製備glp-1受體促效劑的中間體和方法 |
| CN115697968B (zh) * | 2020-05-28 | 2024-03-29 | 杭州中美华东制药有限公司 | (s)-2-氨基-3-(4-(2,3-二甲基吡啶-4-基)苯基丙酸甲酯及其盐的制备方法 |
| CN115667222B (zh) * | 2020-05-28 | 2023-09-29 | 杭州中美华东制药有限公司 | 一种制备glp-1受体激动剂的方法 |
| EP4159737A4 (en) * | 2020-05-28 | 2024-10-09 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | METHOD FOR PREPARING A GLP-1 RECEPTOR AGONIST-FREE BASE |
| TW202206412A (zh) | 2020-05-28 | 2022-02-16 | 美商維特衛治療有限責任公司 | 製備(s)-2-胺基-3-(4-(2,3-二甲基吡啶-4-基)苯基)丙酸甲酯及其鹽酸鹽的方法 |
| JP2023539584A (ja) | 2020-09-01 | 2023-09-15 | 江蘇恒瑞医薬股▲ふん▼有限公司 | 縮合イミダゾール誘導体、その調製方法及びその医薬的応用 |
| US20230382921A1 (en) * | 2020-09-21 | 2023-11-30 | Vtv Therapeutics Llc | Amorphous Form of Isoquinoline Derivative |
| US12454511B2 (en) | 2020-10-08 | 2025-10-28 | Eli Lilly And Company | 6-methoxy-3,4-dihydro-1H-isoquinolin compounds |
| WO2022078152A1 (zh) | 2020-10-12 | 2022-04-21 | 杭州中美华东制药有限公司 | 苯并咪唑酮类glp-1受体激动剂及其用途 |
| US20240246959A1 (en) | 2020-11-27 | 2024-07-25 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Benzimidazole derivative and preparation method therefor and medical use thereof |
| US20240208952A1 (en) | 2021-03-22 | 2024-06-27 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | Thiophene glp-1 receptor agonist and use thereof |
| WO2022202864A1 (ja) | 2021-03-24 | 2022-09-29 | 塩野義製薬株式会社 | 縮合環を有するglp-1受容体作動薬を含有する医薬組成物 |
| CN117500789A (zh) * | 2021-06-17 | 2024-02-02 | 杭州中美华东制药有限公司 | 一种吡啶硼酸酯的制备方法 |
| WO2022262615A1 (zh) * | 2021-06-17 | 2022-12-22 | 杭州中美华东制药有限公司 | 蒽类化合物、其制备方法和医药用途 |
| CN117098758A (zh) | 2021-06-24 | 2023-11-21 | 杭州中美华东制药有限公司 | Glp-1受体激动剂及其组合物和用途 |
| WO2023029979A1 (zh) * | 2021-09-03 | 2023-03-09 | 杭州中美华东制药有限公司 | Glp-1受体激动剂中间体的制备方法 |
| CN118948849A (zh) | 2021-09-08 | 2024-11-15 | 盐野义制药株式会社 | 用于预防和治疗与抗肥胖作用有关的疾病的药物 |
| CA3233453A1 (en) * | 2021-09-28 | 2023-04-06 | Meimei Chen | Solid composition of glp-1 receptor agonist |
| JPWO2024063143A1 (enExample) | 2022-09-22 | 2024-03-28 | ||
| WO2025057134A2 (en) | 2023-09-14 | 2025-03-20 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| US12291530B1 (en) | 2023-11-24 | 2025-05-06 | Ascletis Pharma (China) Co., Limited | GLP-1R agonist and therapeutic method thereof |
| WO2025189141A1 (en) | 2024-03-08 | 2025-09-12 | Annapurna Bio, Inc. | Methods for treating obesity and increasing weight loss |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE795265A (fr) * | 1972-02-09 | 1973-08-09 | Philips Nv | Nouveaux derives de quinoleine a activite pharmacologique |
| EP0233728A1 (en) * | 1986-02-11 | 1987-08-26 | Takeda Chemical Industries, Ltd. | 1,4-Benzoxazine derivatives their production and use |
| US5756532A (en) | 1995-11-06 | 1998-05-26 | American Home Products Corporation | Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives |
| WO2000042026A1 (en) | 1999-01-15 | 2000-07-20 | Novo Nordisk A/S | Non-peptide glp-1 agonists |
| US6815451B2 (en) * | 2001-03-27 | 2004-11-09 | Actelion Pharmaceuticals Ltd. | 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| ES2278064T3 (es) * | 2001-10-19 | 2007-08-01 | Transtech Pharma Inc. | Derivados de beta-carbolina como inhibidores de ptp. |
| EP1458382A1 (en) | 2001-12-21 | 2004-09-22 | Novo Nordisk A/S | Amide derivatives as gk activators |
| CN100432056C (zh) * | 2003-03-26 | 2008-11-12 | 埃科特莱茵药品有限公司 | 四氢异喹啉基乙酰胺衍生物作为阿立新受体拮抗剂的应用 |
| WO2005014532A1 (en) * | 2003-08-08 | 2005-02-17 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions and methods of use |
| RU2284325C2 (ru) | 2003-12-17 | 2006-09-27 | Общество С Ограниченной Ответственностью "Асинэкс Медхим" | Производные фенил-3-аминометил-хинолона-2 в качестве ингибиторов no-синтетазы, способ их получения, биологически активные соединения и фармацевтическая композиция на их основе |
| WO2008118935A1 (en) * | 2007-03-26 | 2008-10-02 | Neurogen Corporation | Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-ones |
| WO2009111700A2 (en) * | 2008-03-07 | 2009-09-11 | Transtech Pharma, Inc. | Oxadiazoanthracene compounds for the treatment of diabetes |
| US8718994B2 (en) | 2008-04-09 | 2014-05-06 | Transtech Pharma, Llc | Ligands for the GLP-1 receptor and methods for discovery thereof |
| CN102378574B (zh) | 2009-03-30 | 2013-11-20 | 转化技术制药公司 | 取代的偶氮蒽衍生物、药物组合物及其使用方法 |
| US8501982B2 (en) | 2010-06-09 | 2013-08-06 | Receptos, Inc. | GLP-1 receptor stabilizers and modulators |
-
2010
- 2010-03-30 CN CN2010800152644A patent/CN102378574B/zh active Active
- 2010-03-30 JP JP2012503599A patent/JP5755217B2/ja active Active
- 2010-03-30 DK DK10779665.8T patent/DK2413693T3/en active
- 2010-03-30 EA EA201171197A patent/EA023430B1/ru not_active IP Right Cessation
- 2010-03-30 AU AU2010232750A patent/AU2010232750B2/en active Active
- 2010-03-30 MX MX2011010347A patent/MX2011010347A/es active IP Right Grant
- 2010-03-30 WO PCT/US2010/029172 patent/WO2010114824A1/en not_active Ceased
- 2010-03-30 SG SG2011063112A patent/SG174205A1/en unknown
- 2010-03-30 BR BRPI1013579-0A patent/BRPI1013579A2/pt not_active IP Right Cessation
- 2010-03-30 MA MA34280A patent/MA33219B1/fr unknown
- 2010-03-30 ES ES10779665.8T patent/ES2553645T3/es active Active
- 2010-03-30 KR KR1020117024153A patent/KR101732978B1/ko active Active
- 2010-03-30 CA CA2757084A patent/CA2757084C/en active Active
- 2010-03-30 EP EP10779665.8A patent/EP2413693B1/en active Active
- 2010-06-29 US US12/825,631 patent/US8383644B2/en active Active
-
2011
- 2011-08-25 TN TN2011000437A patent/TN2011000437A1/fr unknown
- 2011-08-25 IL IL214822A patent/IL214822A/en active IP Right Grant
-
2012
- 2012-12-06 US US13/707,265 patent/US8987295B2/en active Active
-
2015
- 2015-01-23 US US14/603,556 patent/US9175003B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US8383644B2 (en) | 2013-02-26 |
| KR101732978B1 (ko) | 2017-05-08 |
| CN102378574A (zh) | 2012-03-14 |
| US20150148539A1 (en) | 2015-05-28 |
| EA023430B1 (ru) | 2016-06-30 |
| US20110160198A1 (en) | 2011-06-30 |
| IL214822A0 (en) | 2011-11-30 |
| CA2757084A1 (en) | 2010-10-07 |
| MA33219B1 (fr) | 2012-04-02 |
| AU2010232750A1 (en) | 2011-09-08 |
| BRPI1013579A2 (pt) | 2020-11-03 |
| CA2757084C (en) | 2017-08-29 |
| EP2413693B1 (en) | 2015-09-09 |
| TN2011000437A1 (en) | 2013-03-27 |
| JP2012522060A (ja) | 2012-09-20 |
| WO2010114824A8 (en) | 2011-10-06 |
| CN102378574B (zh) | 2013-11-20 |
| SG174205A1 (en) | 2011-10-28 |
| EA201171197A1 (ru) | 2012-04-30 |
| JP5755217B2 (ja) | 2015-07-29 |
| ES2553645T3 (es) | 2015-12-10 |
| HK1164050A1 (en) | 2012-09-21 |
| EA201171197A8 (ru) | 2014-10-30 |
| US9175003B2 (en) | 2015-11-03 |
| EP2413693A4 (en) | 2012-08-22 |
| EP2413693A1 (en) | 2012-02-08 |
| AU2010232750B2 (en) | 2015-10-29 |
| US20130096150A1 (en) | 2013-04-18 |
| IL214822A (en) | 2016-08-31 |
| MX2011010347A (es) | 2011-11-29 |
| KR20120006506A (ko) | 2012-01-18 |
| US8987295B2 (en) | 2015-03-24 |
| WO2010114824A1 (en) | 2010-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2413693T3 (en) | Substituted azoanthracenderivater, pharmaceutical compositions and methods for use thereof | |
| KR101616737B1 (ko) | 당뇨병 치료를 위한 옥사디아조안트라센 화합물 | |
| JP6982054B2 (ja) | Glp−1受容体アゴニストおよびその使用 | |
| HK1164050B (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
| HK1148435B (en) | Oxadiazoanthracene compounds for the treatment of diabetes |